RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: liver cirrhosis
Accession: DOID:5082
browse the term
Definition: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Synonyms: exact_synonym: Hepatic Cirrhosis; Hepatic Fibrosis; cirrhosis; cirrhosis of liver; hepatic cirrhoses; liver cirrhoses; liver fibroses; liver fibrosis
primary_id: MESH:D008103
xref: EFO:0001422 ; ICD10CM:K74.60 ; NCI:C2951
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2m
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Abcb11
ATP-binding cassette, sub-family B member 11
severity
ISO
associated with Hepatitis C, Chronic;DNA:SNP:cds:1331T>C, p.V444A,(rs2287622)(human)
RGD
PMID:29755014
RGD:14402415
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcb4
ATP-binding cassette, sub-family B member 4
severity susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with cholestasis;DNA:mutations: : associated with cystic fibrosis;DNA:SNP:exon:c.504T>C(human)
CTD RGD
PMID:8698195 PMID:18221819 PMID:18482588 PMID:19467940
RGD:14694975 , RGD:4889446
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
G
Ace
angiotensin I converting enzyme
treatment severity no_association
ISO
associated with Chronic Hepatitis B;protein:increased expression:blood serum (human) associated with hepatitis C;DNA:insertion/deletion: associated with liver disease;DNA:insertion/deletion:
RGD
PMID:29335866 PMID:29085215 PMID:19456900 PMID:26681055 PMID:28822808
RGD:25671453 , RGD:40400898 , RGD:39939123 , RGD:11537135 , RGD:25671454
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acta2
actin alpha 2, smooth muscle, aorta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24239723 PMID:24321339 PMID:30097701 PMID:32659284
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
severity
ISO
protein:increased expression, increased activity:liver (rat)
RGD
PMID:16689760
RGD:1598737
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Adar
adenosine deaminase, RNA-specific
ameliorates
ISO
associated with human immunodeficiency virus infectious disease, hepatitis C;DNA:SNPs:exon 2, 3' utr:multiple (human)
RGD
PMID:29018269
RGD:125097516
NCBI chr 3:89,622,321...89,660,756
Ensembl chr 3:89,622,329...89,660,753
G
Adipoq
adiponectin, C1Q and collagen domain containing
severity
ISO
protein:increased expression:plasma
RGD
PMID:16115302
RGD:5686674
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
IEP
mRNA:decreased expression:liver (mouse)
RGD
PMID:17006986
RGD:1599139
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adra1a
adrenergic receptor, alpha 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16782692
NCBI chr14:66,872,705...67,009,549
Ensembl chr14:66,872,700...67,008,617
G
Ager
advanced glycosylation end product-specific receptor
ISO
mRNA:decreased expression:lung (liver)
RGD
PMID:22669512
RGD:7245533
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15613622 PMID:21873937
RGD:8549465
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Ahr
aryl-hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29416063
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akap12
A kinase anchor protein 12
ISO
mRNA,protein:increased expression:liver
RGD
PMID:23925424
RGD:14348971
NCBI chr10:4,216,329...4,309,471
Ensembl chr10:4,216,380...4,309,470
G
Alad
aminolevulinate, delta-, dehydratase
ISO IEP
CTD Direct Evidence: marker/mechanism protein:decreased activity:liver (human)
CTD RGD
PMID:25226513 PMID:6848403
RGD:15042852
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Alb
albumin
disease_progression
ISO
associated with Head and Neck Neoplasms; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17977396 PMID:21851314 PMID:23285146
RGD:11035282
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Anks6
ankyrin repeat and sterile alpha motif domain containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23793029
NCBI chr 4:47,015,365...47,057,339
Ensembl chr 4:47,015,669...47,057,427
G
Apoa1
apolipoprotein A-I
ISO
protein:decreased expression:serum (human)
RGD
PMID:27106140
RGD:25671439
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
G
Arrb1
arrestin, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 7:99,184,356...99,255,979
Ensembl chr 7:99,184,673...99,255,978
G
Arrb2
arrestin, beta 2
ISO
protein:increased expression:hepatic artery
RGD
PMID:17256744
RGD:1625784
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Atg5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33549628
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
G
Atm
ataxia telangiectasia mutated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36526012
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp7b
ATPase, copper transporting, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25134866
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
G
Axin1
axin 1
ISO
protein:decreased expression:liver (human)
RGD
PMID:31514071
RGD:150530482
NCBI chr17:26,350,294...26,414,784
Ensembl chr17:26,357,662...26,414,785
G
Azgp1
alpha-2-glycoprotein 1, zinc
ISO
associated with hepatocellular carcinoma;protein:decreased expression:liver: mRNA:decreased expression:liver
RGD
PMID:22625427 PMID:26902423
RGD:153350130 , RGD:153350133
NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495
G
Azin1
antizyme inhibitor 1
ISO
associated with hepatitis B;DNA SNP: :rs2679757 (human) associated with hepatocellular carcinoma;RNA:increased editing:liver
RGD
PMID:21586232 PMID:23291631
RGD:14700702 , RGD:14700705
NCBI chr15:38,487,674...38,523,506
Ensembl chr15:38,487,671...38,519,510
G
Bambi
BMP and activin membrane-bound inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097701
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
G
Becn1
beclin 1, autophagy related
ISO
protein:increased expression:skeletal muscle
RGD
PMID:22895779
RGD:11561934
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
C1qb
complement component 1, q subcomponent, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
G
Casp3
caspase 3
IEP
associated with cholestasis
RGD
PMID:29105510
RGD:13782297
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
IEP
associated with cholestasis
RGD
PMID:29105510
RGD:13782297
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
IEP
associated with cholestasis
RGD
PMID:29105510
RGD:13782297
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
CTD RGD
PMID:20697377 PMID:32626927
RGD:401959337
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
severity treatment
ISO IMP
DNA:SNAP, haplotype: :rs11652536(human)
RGD
PMID:28011329 PMID:20978355 PMID:28011329
RGD:14995306 , RGD:14995328 , RGD:14995306
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccn2
cellular communication network factor 2
ameliorates
ISO IMP IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16652398 PMID:17657819 PMID:26396155 PMID:36469291 PMID:36469291 PMID:26946098 More...
RGD:243048439 , RGD:243048439 , RGD:40925947
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Ccnd2
cyclin D2
ISO
associated with hepatitis B;mRNA:decreased expression:Peripheral Blood Mononuclear Cell
RGD
PMID:33320844
RGD:151664743
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Ccr1
C-C motif chemokine receptor 1
ISO
associated with Fatty Liver
RGD
PMID:19280268
RGD:5688143
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd14
CD14 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20353583
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd163
CD163 antigen
exacerbates
ISO
associated with Chronic Hepatitis B, Chronic Hepatitis C;protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human)
RGD
PMID:24623375 PMID:26339412
RGD:127285681 , RGD:11251207
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd36
CD36 molecule
ISO
associated with Hypertension, Portal
RGD
PMID:22648712
RGD:6893541
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd9
CD9 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32659284
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cenpc1
centromere protein C1
ISO
associated with Anticentromere antibody positivity
RGD
PMID:25220385
RGD:27372886
NCBI chr 5:86,159,877...86,214,325
Ensembl chr 5:86,159,883...86,213,442
G
Chrm3
cholinergic receptor, muscarinic 3, cardiac
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
G
Cldn1
claudin 1
severity
IEP
associated with hepatitis C, Chronic;mRNA,protein:increased expression:liver (human)
RGD
PMID:21620107
RGD:26884347
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11433348 PMID:21863215
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15765409
NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
G
Col1a1
collagen, type I, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21863215 PMID:24239723 PMID:24321339 PMID:26396155 PMID:32659284
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col3a1
collagen, type III, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1880254 PMID:2566230 PMID:11167689 PMID:15787813 PMID:16679477
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col5a2
collagen, type V, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442
G
Commd1
COMM domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17919502
NCBI chr11:22,849,728...22,934,539
Ensembl chr11:22,846,136...22,932,382
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:26396155
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Cpeb1
cytoplasmic polyadenylation element binding protein 1
ISO
associated with Hepatitis C, Chronic; protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 7:80,996,774...81,105,207
Ensembl chr 7:80,996,774...81,105,213
G
Cpeb4
cytoplasmic polyadenylation element binding protein 4
ISO
associated with Hepatitis C, Chronic; protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr11:31,820,911...31,885,635
Ensembl chr11:31,822,211...31,885,634
G
Crp
C-reactive protein, pentraxin-related
ISO
associated with Hepatitis C, Chronic;protein:decreased expression:serum
RGD
PMID:21806828
RGD:9491781
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1r
colony stimulating factor 1 receptor
exacerbates
ISO
associated with hepatitis C, liver cirrhosis;protein:increased expression:serum (human)
RGD
PMID:26437001
RGD:11079330
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21047994
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Cxcl10
C-X-C motif chemokine ligand 10
severity disease_progression
ISO
mRNA:increased expression:liver associated with Chronic Hepatitis B;
RGD
PMID:11418676 PMID:28067328 PMID:29105936
RGD:27095892 , RGD:27095955 , RGD:27095953
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33069761
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
G
Cxcl15
C-X-C motif chemokine ligand 15
disease_progression
EXP ISO
CTD Direct Evidence: therapeutic mRNA, protein:increased expression:liver, serum (human)
CTD RGD
PMID:15763341 PMID:21731723
RGD:26884357
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyba
cytochrome b-245, alpha polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cygb
cytoglobin
ISO
RGD
PMID:16581302 PMID:11320098
RGD:9685176 , RGD:68672
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27565560
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24381012
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24381012
NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17973928
RGD:405820211
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Dgat1
diacylglycerol O-acyltransferase 1
treatment
IMP
associated with Non-alcoholic Fatty Liver Disease;
RGD
PMID:18000880
RGD:10400849
NCBI chr15:76,386,215...76,396,167
Ensembl chr15:76,386,215...76,396,153
G
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24381012
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:24211420
RGD:9588224
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Drd4
dopamine receptor D4
disease_progression
ISO
DNA:repeats:exon:
RGD
PMID:23298155
RGD:401959737
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Edn1
endothelin 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:20628429
RGD:4144843
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Egfr
epidermal growth factor receptor
severity
ISO
associated with non-alcoholic fatty liver disease;protein:increased expression:plasma
RGD
PMID:28650518
RGD:14401722
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egr1
early growth response 1
ISO
protein:increased expression:liver, nucleus
RGD
PMID:22292946
RGD:10395298
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Eln
elastin
severity
ISO
protein:increased expression:liver:
RGD
PMID:22223197
RGD:9585666
NCBI chr 5:134,731,449...134,776,300
Ensembl chr 5:134,731,447...134,776,177
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
associated with hepatitis C
RGD
PMID:15651265
RGD:9685530
NCBI chr 2:25,285,886...25,291,335
Ensembl chr 2:25,285,886...25,291,333
G
Ephb2
Eph receptor B2
ameliorates
IMP
associated with malaria;
RGD
PMID:25784101
RGD:127285023
NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299
G
F2
coagulation factor II
severity
ISO
CTD Direct Evidence: marker/mechanism protein:decreased activity:plasma (human) protein:decreased expression:plasma (human) protein:increased expression:plasma (human)
CTD RGD
PMID:10216089 PMID:15726661 PMID:29768734 PMID:9863491
RGD:14985236 , RGD:14985235 , RGD:14401592
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F2r
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21037076
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
G
F3
coagulation factor III, tissue factor
severity treatment
IMP ISO
mRNA, protein:increased expression, increased activity:monocyte (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10216089 PMID:21037076 PMID:9863491 PMID:15946135 PMID:28883694
RGD:11341737 , RGD:14401592 , RGD:14401577 , RGD:14401724
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
F5
coagulation factor V
disease_progression susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18485088 PMID:10520855 PMID:26226452
RGD:14700663 , RGD:14700659
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
Fah
fumarylacetoacetate hydrolase
ISO
RGD
PMID:27510266
RGD:14398823
NCBI chr 7:84,234,367...84,255,150
Ensembl chr 7:84,234,367...84,255,930
G
Farsb
phenylalanyl-tRNA synthetase, beta subunit
ISO
ClinVar Annotator: match by term: Liver cirrhosis
ClinVar
PMID:29979980
NCBI chr 1:78,394,593...78,465,530
Ensembl chr 1:78,394,612...78,465,534
G
Fbn1
fibrillin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26396155 PMID:14661032
RGD:12910489
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Fgf15
fibroblast growth factor 15
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28673684
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17093919
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fgf7
fibroblast growth factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17692400
NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105
G
Fgfr2
fibroblast growth factor receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17692400
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fgfr4
fibroblast growth factor receptor 4
ISO
associated with hepatocellular carcinoma; DNA:SNP:cds: p.G388R (rs351855) (human)
RGD
PMID:25860955
RGD:11057080
NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572
G
Flt1
FMS-like tyrosine kinase 1
ISO
mRNA:increased expressin:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11981751 PMID:11981751
RGD:634296
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Focad
focadhesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35864190
NCBI chr 4:88,012,858...88,329,248
Ensembl chr 4:88,012,866...88,329,248
G
Foxo3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33372984
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
G
Fubp1
far upstream element (FUSE) binding protein 1
ISO
associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)
RGD
PMID:25995247
RGD:151361196
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
Gc
vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24381012
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gch1
GTP cyclohydrolase 1
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:16799985
RGD:329970289
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
RGD
PMID:22942279
RGD:11049542
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gdf1
growth differentiation factor 1
disease_progression
ISO
associated with Stable Angina; protein:decreased expression:blood plasma (human)
RGD
PMID:36268984
RGD:243065147
NCBI chr 8:70,768,425...70,784,242
Ensembl chr 8:70,768,425...70,784,242 Ensembl chr 8:70,768,425...70,784,242
G
Ggt1
gamma-glutamyltransferase 1
disease_progression severity
ISO
associated with Hepatitis B, Chronic;
RGD
PMID:27793641 PMID:25254524 PMID:15997630
RGD:14701041 , RGD:14747031 , RGD:14747030
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gli3
GLI-Kruppel family member GLI3
ISO
mRNA:increased expression:serum:
RGD
PMID:32319630
RGD:155791681
NCBI chr13:15,638,308...15,904,611
Ensembl chr13:15,637,820...15,904,611
G
Glul
glutamate-ammonia ligase
severity
ISO
associated with congestive heart failure
RGD
PMID:30950843
RGD:401793761
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Golm1
golgi membrane protein 1
ISO
protein:increased expression:serum
RGD
PMID:21140449
RGD:401827118
NCBI chr13:59,782,810...59,823,598
Ensembl chr13:59,782,440...59,823,625
G
Gp1ba
glycoprotein 1b, alpha polypeptide
treatment
ISO
RGD
PMID:31851564
RGD:42722628
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
G
Gpc3
glypican 3
ISO
protein:increased expression:blood serum (human)
RGD
PMID:28801286
RGD:243065135
NCBI chr X:51,361,303...51,702,851
Ensembl chr X:51,361,303...51,702,827
G
Gpr137b-ps
G protein-coupled receptor 137B, pseudogene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33069761
NCBI chr13:12,628,954...12,665,284
Ensembl chr13:12,630,627...12,665,175 Ensembl chr13:12,630,627...12,665,175
G
Gpt
glutamic pyruvic transaminase, soluble
severity
ISO
associated with Hepatitis B, Chronic;
RGD
PMID:30665287
RGD:14975252
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Grk2
G protein-coupled receptor kinase 2
ISO
associated with hepatitis B;protein:increased expression:mesenteric artery (human) protein:increased expression:hepatic artery
RGD
PMID:23742775 PMID:17256744
RGD:13792718 , RGD:1625784
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Gstm1
glutathione S-transferase, mu 1
ISO
protein:decreased expression:liver (rat) associated with Hepatitis C, Chronic
RGD
PMID:20141739 PMID:26548378
RGD:7771534 , RGD:11097429
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
ISO
associated with Hepatitis C, Chronic
RGD
PMID:26548378
RGD:11097429
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
associated with Hepatitis C, Chronic;DNA:SNPs: :rs910049, rs3135363(human) associated with hepatitis B;DNA:polymorphism: :HLA-DQA1*0104 (human)
RGD
PMID:23321320 PMID:17845309
RGD:14401563 , RGD:126925986
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility
ISO
associated with Schistosomiasis Japonica;DNA:polymorphisms: :HLA-DQB1*0303, HLA-DQB1*0601, HLA-DQB1*0609(human)
RGD
PMID:11336748
RGD:36049755
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility
ISO
associated with Schistosomiasis Japonica;DNA:polymorphisms: :HLA-DRB1*0901, HLA-DRB1*1302, HLA-DRB1*1501(human)
RGD
PMID:11336748
RGD:36049755
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-Pa
histocompatibility 2, P region alpha locus
severity
ISO
DAN:polymorphism: :
RGD
PMID:10203020
RGD:14694972
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
G
Hc
hemolytic complement
disease_progression
ISO
associated with Hepatitis C, Chronic;DNA:SNPs: :rs17611, rs2300929 (human)
RGD
PMID:15995705
RGD:1600592
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hdac2
histone deacetylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27396813
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutations: :p.H63D, p.C282Y (human)
RGD
PMID:27816425
RGD:14701047
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17097021
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hhip
Hedgehog-interacting protein
IEP
mRNA:decreased expression:liver:
RGD
PMID:19815628
RGD:11552602
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36126797
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hnf4a
hepatic nuclear factor 4, alpha
ISO
protein:decreased expression:liver:
RGD
PMID:20876809
RGD:12904747
NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830
G
Hp
haptoglobin
ISO
associated with Hepatitis C, Chronic;protein:decreased expression:serum
RGD
PMID:21806828
RGD:9491781
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hras
Harvey rat sarcoma virus oncogene
ISO
mRNA:increased expression:liver (human)
RGD
PMID:7535324
RGD:14694815
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15199296
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Icam1
intercellular adhesion molecule 1
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:missense mutations, haplotype:cds:p.G241R, p.K469E (human) associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
RGD
PMID:18233990 PMID:32626927
RGD:14402042 , RGD:401959337
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ido2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
G
Ifna1
interferon alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18665156
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
G
Ifna2
interferon alpha 2
treatment
ISO
associated with extrahepatic cholestasis;human protein in a rat model
RGD
PMID:7646558
RGD:21406433
NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149
G
Ifng
interferon gamma
IDA ISO
RGD
PMID:21664391 PMID:12389079
RGD:6893452 , RGD:10755749
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ifnl2
interferon lambda 2
treatment
ISO
associated with Hepatitis C;DNA:SNP: :rs8099917 (human)
RGD
PMID:23145809
RGD:11528558
NCBI chr 7:28,208,209...28,209,957
Ensembl chr 7:28,208,261...28,209,880
G
Igf1r
insulin-like growth factor I receptor
susceptibility
ISO
associated with Hepatis B virus;DNA:SNP:3'UTR:rs3743251(human)
RGD
PMID:24758241
RGD:14985227
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2
insulin-like growth factor 2
severity
ISO
associated with non-alcoholic fatty liver disease;protein:decreased expression:plasma
RGD
PMID:28650518
RGD:14401722
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Igfbp2
insulin-like growth factor binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
G
Il10
interleukin 10
severity no_association
ISO
associated with Hepatitis C, Chronic;DNA:SNP:promoter:-592C>A (human) DNA:SNP:promoter:-592C>A (rs1800872) (human) DNA:SNP:promoter:-1082G>A (rs1800896) (human) associated with Hepatitis C, Chronic;DNA:SNP:promoter:-1082 G>A (human)
RGD
PMID:27660094 PMID:26909998 PMID:26909998 PMID:27660094
RGD:14975134 , RGD:14975152 , RGD:14975152 , RGD:14975134
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il18
interleukin 18
severity
ISO
protein:increased expression:plasma: associated with Hepatitis C, Chronic;mRNA:increased expression:PBMC:
RGD
PMID:12462332 PMID:19740312 PMID:19740312
RGD:14695542 , RGD:14696656 , RGD:14696656
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18bp
interleukin 18 binding protein
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:12462332
RGD:14695542
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il1b
interleukin 1 beta
ISO
associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
RGD
PMID:32626927
RGD:401959337
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
severity
IEP
associated with Schistosomiasis Japonica
RGD
PMID:31200771
RGD:39938956
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il2
interleukin 2
treatment
IDA
associated with sclerosing cholangitis
RGD
PMID:29698570
RGD:14928214
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il21
interleukin 21
exacerbates
ISO
associated with Chronic Hepatitis B;mRNA:increased expression: liver (human)
RGD
PMID:24611989
RGD:127285546
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il27
interleukin 27
ISO
associated with hepatitis B;protein:increased expression:blood serum (human)
RGD
PMID:22230324
RGD:126790507
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il33
interleukin 33
severity
IEP ISO
associated with Schistosomiasis Japonica
RGD
PMID:31200771 PMID:31053540
RGD:39938956 , RGD:40400690
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12830005
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irf5
interferon regulatory factor 5
severity
ISO IMP
RGD
PMID:27942586 PMID:27942586
RGD:40924562 , RGD:40924562
NCBI chr 6:29,526,129...29,541,874
Ensembl chr 6:29,526,624...29,541,870
G
Itgb6
integrin beta 6
disease_progression
ISO
associated with Hepatitis C, Chronic;mRNA:increased expression:liver
RGD
PMID:18221819
RGD:2302245
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
G
Itih4
inter alpha-trypsin inhibitor, heavy chain 4
ISO
associated with hepatitis B;protein:increased expression:serum
RGD
PMID:24836184
RGD:40903002
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
G
Jak1
Janus kinase 1
treatment
IEP
associated with Schistosomiasis Japonica
RGD
PMID:27439782
RGD:19165137
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Jak2
Janus kinase 2
severity
IEP
mRNA:increased expression:liver (human)
RGD
PMID:26385087
RGD:18337263
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jund
jun D proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17133482
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Kdr
kinase insert domain protein receptor
disease_progression
ISO
associated with Chronic Hepatitis
RGD
PMID:27323788
RGD:126908000
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Klf5
Kruppel-like transcription factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33549628
NCBI chr14:99,536,127...99,550,848
Ensembl chr14:99,536,127...99,552,472
G
Klkb1
kallikrein B, plasma 1
ISO
RGD
PMID:14986822
RGD:7297050
NCBI chr 8:45,719,725...45,747,872
Ensembl chr 8:45,719,726...45,747,896
G
Krt18
keratin 18
severity
ISO
protein:increased expression: serum (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:20538000 PMID:9011570 PMID:29023872
RGD:1624318 , RGD:18337484
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt8
keratin 8
ISO
protein:increased phosphorylation:liver (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:20538000 PMID:11372009 PMID:15368451
RGD:1600062 , RGD:14401583
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Lamc2
laminin, gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
G
Lbp
lipopolysaccharide binding protein
ISO
protein:increased expression:liver
RGD
PMID:17918268
RGD:2292126
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Lgals1
lectin, galactose binding, soluble 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
G
Lgals3
lectin, galactose binding, soluble 3
ISO
RGD
PMID:16549783
RGD:9685224
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lgals3bp
lectin, galactoside-binding, soluble, 3 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr11:118,283,573...118,292,787
Ensembl chr11:118,283,577...118,292,918
G
Lox
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Loxl1
lysyl oxidase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097701
NCBI chr 9:58,195,006...58,220,495
Ensembl chr 9:58,195,021...58,220,469
G
Lum
lumican
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr10:97,401,363...97,408,565
Ensembl chr10:97,400,990...97,408,565
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
ISO
protein:increased expression:skeletal muscle
RGD
PMID:22895779
RGD:11561934
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Mapk14
mitogen-activated protein kinase 14
exacerbates
IMP
RGD
PMID:23271722
RGD:151665348
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mbl2
mannose-binding lectin (protein C) 2
severity susceptibility
ISO
associated with hepatitis C; DNA:haplotype:promoter, exon: associated with hepatitis B;DNA:SNP:exon:
RGD
PMID:20570631 PMID:26857650
RGD:14696832 , RGD:14696836
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mgll
monoglyceride lipase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30301768
NCBI chr 6:88,701,397...88,805,342
Ensembl chr 6:88,701,394...88,805,342
G
Mical2
microtubule associated monooxygenase, calponin and LIM domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32659284
NCBI chr 7:111,825,032...112,012,311
Ensembl chr 7:111,825,063...112,012,313
G
Mir122
microRNA 122
ISO
mRNA:decreased expression:blood (human)
RGD
PMID:27528885
RGD:151361113
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir126a
microRNA 126a
ISO
RNA:increased expression:duodenum
RGD
PMID:22574900
RGD:401850781
NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441
G
Mir145a
microRNA 145a
IEP
miRNA:decreased expression:liver (human)
RGD
PMID:27289031
RGD:15039397
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
G
Mir146
microRNA 146
exacerbates
ISO
associated with hepatitis B;miRNA:increased expression:liver (human) associated with hepatitis B; miRNA:decreased expression: liver, peripheral blood mononuclear cell, blood serum (human)
RGD
PMID:25805734 PMID:31086599
RGD:126925149 , RGD:126925162
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir152
microRNA 152
ISO
miRNA:decreased expression:serum
RGD
PMID:31258681
RGD:19165153
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir153
microRNA 153
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr12:117,214,437...117,214,505
Ensembl chr12:117,214,437...117,214,505
G
Mir155
microRNA 155
ISO
RGD
PMID:29420849
RGD:21409750
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir193a
microRNA 193a
ISO
associated with hepatocellular carcinoma; RNA:decreased expression:liver (human)
RGD
PMID:24330766
RGD:153344567
NCBI chr11:79,602,795...79,602,860
Ensembl chr11:79,602,795...79,602,860
G
Mir200a
microRNA 200a
ISO
RNA:decreased expression:liver:
RGD
PMID:32319630
RGD:155791681
NCBI chr 4:156,139,353...156,139,442
Ensembl chr 4:156,139,353...156,139,442
G
Mir200b
microRNA 200b
treatment
IMP
associated with primary sclerosing cholangitis;
RGD
PMID:28634212
RGD:14928323
NCBI chr 4:156,140,138...156,140,207
Ensembl chr 4:156,140,138...156,140,207
G
Mir203
microRNA 203
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:32659284
NCBI chr12:112,097,314...112,097,389
Ensembl chr12:112,097,314...112,097,389
G
Mir215
microRNA 215
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:185,045,778...185,045,889
Ensembl chr 1:185,045,778...185,045,889
G
Mir21a
microRNA 21a
onset treatment disease_progression ameliorates
ISO IEP
associated with nonalcoholic fatty liver disease;miRNA:increased expression:liver, plasma associated with chronic hepatitis B
RGD
PMID:27320964 PMID:30419452 PMID:30147020 PMID:20625373 PMID:26946098
RGD:14695024 , RGD:41404717 , RGD:41404701 , RGD:41404667 , RGD:40925947
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir221
microRNA 221
IEP
RNA:increased expression:liver
RGD
PMID:22267590
RGD:151709001
NCBI chr X:19,012,533...19,012,627
Ensembl chr X:19,012,533...19,012,627
G
Mir222
microRNA 222
IEP
RNA:increased expression:liver
RGD
PMID:22267590
RGD:151709001
NCBI chr X:19,013,132...19,013,210
Ensembl chr X:19,013,132...19,013,210
G
Mir223
microRNA 223
severity
ISO
associated with Chronic Hepatitis C; associated with Chronic Hepatitis B; RNA:decreased expression:serum: associated with Chronic HepatitisC; RNA:decreased expression:serum: RNA:altered expression:serum,liver
RGD
PMID:28211229 PMID:24595450 PMID:25391771 PMID:28646120
RGD:21408569 , RGD:21408583 , RGD:21408580 , RGD:21408574
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir29c
microRNA 29c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:194,719,855...194,719,942
Ensembl chr 1:194,719,855...194,719,942
G
Mir302c
microRNA 302c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 3:127,339,012...127,339,079
Ensembl chr 3:127,339,012...127,339,079
G
Mir30a
microRNA 30a
ISO
RNA:decreased expression:liver
RGD
PMID:29587268
RGD:35673290
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr15:68,209,264...68,209,359
Ensembl chr15:68,209,264...68,209,359
G
Mir30c-1
microRNA 30c-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:120,626,731...120,626,819
Ensembl chr 4:120,626,731...120,626,819
G
Mir30c-2
microRNA 30c-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:23,330,782...23,330,865
Ensembl chr 1:23,330,782...23,330,865
G
Mir345
microRNA 345
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36126797
NCBI chr12:108,802,899...108,802,994
Ensembl chr12:108,802,899...108,802,994
G
Mir376c
microRNA 376c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr12:109,689,152...109,689,237
Ensembl chr12:109,689,152...109,689,237
G
Mir503
microRNA 503
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:52,142,861...52,142,931
Ensembl chr X:52,142,861...52,142,931
G
Mir764
microRNA 764
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:145,785,255...145,785,362
Ensembl chr X:145,785,255...145,785,362
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:21382168
RGD:7207361
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
severity
ISO
protein:decreased expression:serum (rat)
RGD
PMID:16124044 PMID:14606082
RGD:7207132 , RGD:7207396
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
severity
ISO
protein:decreased expression:serum (rat)
RGD
PMID:14606082 PMID:16124044
RGD:7207132 RGD:7207396
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15763341 PMID:26396155 PMID:23411180
RGD:8657103
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mpo
myeloperoxidase
disease_progression
ISO
DNA:SNP:promoter:-463G>A( rs2333227)(human)
RGD
PMID:19731237
RGD:26923907
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mrtfa
myocardin related transcription factor A
ameliorates
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:33779332 PMID:26693892
RGD:11555770
NCBI chr15:80,896,482...81,074,937
Ensembl chr15:80,896,482...81,074,958
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP: :677C>T(human)
RGD
PMID:25987440
RGD:14696749
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Muc17
mucin 17, cell surface associated
ISO
mRNA:increased expression:ileum
RGD
PMID:22172882
RGD:7349362
NCBI chr 5:137,163,772...137,202,809
Ensembl chr 5:137,163,770...137,202,830
G
Muc2
mucin 2
ISO
mRNA:increased expression:ileum
RGD
PMID:22172882
RGD:7349362
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Myc
myelocytomatosis oncogene
IEP
mRNA,protein:increased expression:liver
RGD
PMID:23770341
RGD:14695015
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:23793039 PMID:22732220
RGD:10412731
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
protein:decreased activity:liver (rat)
RGD
PMID:10535886 PMID:12759254
RGD:7775034 , RGD:7794774
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Npc1
NPC intracellular cholesterol transporter 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22216111
NCBI chr18:12,322,751...12,369,851
Ensembl chr18:12,322,749...12,369,457
G
Nppa
natriuretic peptide type A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15613622
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nppb
natriuretic peptide type B
severity
ISO
protein:increased expression:plasma:
RGD
PMID:9350073 PMID:23940514
RGD:7246914 , RGD:7248670
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:29078262
RGD:13442479
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment severity
ISO IMP
mRNA:altered expression:liver, kidney (rat) mRNA:altered expression:liver (mouse)
RGD
PMID:30308196 PMID:19418582
RGD:15042865 , RGD:15042868
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
P2rx7
purinergic receptor P2X, ligand-gated ion channel, 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32721574
NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
G
Parp1
poly (ADP-ribose) polymerase family, member 1
ISO
associated with Hepatitis B;mRNA:decreased expression:blood, mononuclear cell
RGD
PMID:25755481
RGD:11073733
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pcolce
procollagen C-endopeptidase enhancer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 5:137,603,369...137,609,666
Ensembl chr 5:137,603,365...137,612,046
G
Pdcd10
programmed cell death 10
ISO
protein:increased expression:liver (human)
RGD
PMID:32186778
RGD:401827111
NCBI chr 3:75,423,797...75,464,159
Ensembl chr 3:75,423,797...75,464,163
G
Pdgfa
platelet derived growth factor, alpha
ISO
ClinVar Annotator: match by term: Hepatic fibrosis
ClinVar
PMID:25741868
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA: increased expression
RGD
PMID:22539040 PMID:22407906
RGD:6482830 , RGD:6482858
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfd
platelet-derived growth factor, D polypeptide
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:17397961
RGD:9854631
NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850
G
Pdia3
protein disulfide isomerase associated 3
severity
ISO
protein:decreased expression:liver:
RGD
PMID:24562544 PMID:24562544
RGD:9999176 , RGD:9999176
NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
G
Pecam1
platelet/endothelial cell adhesion molecule 1
ISO
protein:increased expression:blood microparticle (human)
RGD
PMID:22465620
RGD:6771231
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pemt
phosphatidylethanolamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29416063
NCBI chr11:59,861,440...59,937,394
Ensembl chr11:59,861,440...59,937,315
G
Pgf
placental growth factor
ISO
mRNA, protein:increased expression:liver, serum
RGD
PMID:21520176
RGD:6483607
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Phkg2
phosphorylase kinase, gamma 2 (testis)
ISO
DNA:missense mutation, nonsense mutation (human)
RGD
PMID:9384616
RGD:737725
NCBI chr 7:127,169,252...127,182,479
Ensembl chr 7:127,172,512...127,182,479
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
treatment
ISO
associated with Schistosomiasis Japonica
RGD
PMID:29323718
RGD:38599216
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pkhd1
polycystic kidney and hepatic disease 1
IMP
DNA:deletion:exon:
RGD
PMID:17519956
RGD:14700917
NCBI chr 1:20,128,003...20,688,306
Ensembl chr 1:20,128,003...20,688,288
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18481824 PMID:26396155
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plaur
plasminogen activator, urokinase receptor
disease_progression
ISO
protein:increased expression:serum
RGD
PMID:22098627
RGD:6484116
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481
G
Pnpla3
patatin-like phospholipase domain containing 3
severity disease_progression
ISO
associated with non-alcoholic fatty liver disease:DNA:SNP: :rs738409 (p.I148M) (human) associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human) associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:20648474 PMID:31377187 PMID:29674183
RGD:14981584 , RGD:14981594 , RGD:14981591
NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
G
Postn
periostin, osteoblast specific factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32344006
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
G
Pten
phosphatase and tensin homolog
ISO IEP
CTD Direct Evidence: marker/mechanism associated with schistosomiasis;protein, mRNA:decreased expression:liver (mouse)
CTD RGD
PMID:26023714 PMID:31907686
RGD:127285596
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptgs2
prostaglandin-endoperoxide synthase 2
severity
ISO
human gene in mouse model
RGD
PMID:29109031
RGD:14695008
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptn
pleiotrophin
ISO
protein:increased expression:liver (rat)
RGD
PMID:18381592
RGD:9834946
NCBI chr 6:36,691,863...36,787,114
Ensembl chr 6:36,691,864...36,787,155
G
Rad50
RAD50 double strand break repair protein
treatment
ISO
RGD
PMID:21893185
RGD:9831391
NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146
G
Rbp4
retinol binding protein 4, plasma
severity
ISO
associated with lived disease; protein:decreased expression:blood serum (human)
RGD
PMID:17337499
RGD:329845879
NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
G
Reg3b
regenerating islet-derived 3 beta
ISO
protein:increased expression:serum (human)
RGD
PMID:10550309
RGD:9831380
NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
RGD
PMID:32626927
RGD:401959337
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Reln
reelin
ISO
protein:altered expression:plasma (human)
RGD
PMID:18449964
RGD:2317777
NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700
G
Ren1
renin 1 structural
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15613622
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:20,413,980...20,428,328
Ensembl chr X:20,416,026...20,428,328
G
Rgs2
regulator of G-protein signaling 2
ISO
RGD
PMID:19003918
RGD:10449440
NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
G
Serpina6
serine (or cysteine) peptidase inhibitor, clade A, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:103,612,889...103,623,477
Ensembl chr12:103,612,889...103,623,471
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
DNA:polymorphism:promoter:
RGD
PMID:25987440
RGD:14696749
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Serpinh1
serine (or cysteine) peptidase inhibitor, clade H, member 1
disease_progression treatment
ISO IEP IMP
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica associated with Schistosomiasis Japonica;mRNA:increased expression:liver (human) associated with schistosomiasis;mRNA:increased expression:liver (human)
CTD RGD
PMID:24321339 PMID:31612672 PMID:32410640 PMID:24295791 PMID:24295791 PMID:25111595 More...
RGD:41412161 , RGD:41410785 , RGD:41410784 , RGD:41410784 , RGD:41410780
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
G
Shc1
src homology 2 domain-containing transforming protein C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32659284
NCBI chr 3:89,325,858...89,337,336
Ensembl chr 3:89,325,750...89,337,334
G
Slc13a4
solute carrier family 13 (sodium/sulfate symporters), member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:35,244,888...35,285,061
Ensembl chr 6:35,244,892...35,285,066
G
Slc17a2
solute carrier family 17 (sodium phosphate), member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:23,990,924...24,009,174
Ensembl chr13:23,990,976...24,009,163
G
Slc22a8
solute carrier family 22 (organic anion transporter), member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
G
Slc30a10
solute carrier family 30, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926781
NCBI chr 1:185,187,045...185,200,959
Ensembl chr 1:185,187,045...185,200,959
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
susceptibility
ISO
associated with alcohol use disorder;DNA:deletion:promoter:-1212_-1255 (human)
RGD
PMID:11236836
RGD:36947396
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Smad3
SMAD family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21605584
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smad7
SMAD family member 7
ISO
associated with hepatocellular carcinoma; mRNA:increased expression:liver (human)
RGD
PMID:25602745
RGD:14401589
NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006
G
Smo
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:22994359
RGD:150521663
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Socs1
suppressor of cytokine signaling 1
exacerbates
IMP
associated with Chemical and Drug Induced Liver Injury;
RGD
PMID:30097285
RGD:150573810
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Sod2
superoxide dismutase 2, mitochondrial
disease_progression
ISO
DNA:SNP:cds:p.Ala16Val(rs1799725)(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32659284 PMID:19731237
RGD:26923907
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Spag9
sperm associated antigen 9
ISO
associated with Human Viral Hepatitis
RGD
PMID:29344208
RGD:30296654
NCBI chr11:93,886,794...94,016,919
Ensembl chr11:93,886,917...94,016,911
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23408952
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Spint1
serine protease inhibitor, Kunitz type 1
ISO
mRNA:increased expression:spleen:
RGD
PMID:15086199
RGD:10043112
NCBI chr 2:119,067,841...119,079,995
Ensembl chr 2:119,067,843...119,080,008
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16221502
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17133483
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat3
signal transducer and activator of transcription 3
IMP
RGD
PMID:22687286
RGD:6892914
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:23841464
RGD:11060135
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21037076 PMID:35101388 PMID:36368619 PMID:30686515
RGD:14985228
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb2
transforming growth factor, beta 2
ISO
RGD
PMID:30686515
RGD:14985228
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tgm2
transglutaminase 2, C polypeptide
severity treatment
IEP IMP
associated with Schistosomiasis Japonica
RGD
PMID:31200771 PMID:31200771
RGD:39938956 , RGD:39938956
NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18407596
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Thpo
thrombopoietin
ISO
mRNA:decreased expression:liver
RGD
PMID:9794189
RGD:1580082
NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
G
Tlr2
toll-like receptor 2
IMP
RGD
PMID:24815695
RGD:15090811
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr3
toll-like receptor 3
susceptibility
ISO
DNA:snp: :rs3775290(human)
RGD
PMID:26024592
RGD:21079416
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Tlr4
toll-like receptor 4
treatment
ISO
protein:increased expression:intestine: associated with chronic intermittent hypoxia
RGD
PMID:27061671 PMID:12610323 PMID:32626927 PMID:20006396 PMID:26809353
RGD:14697732 , RGD:597538466 , RGD:401959337 , RGD:18182934 , RGD:14700654
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tmem67
transmembrane protein 67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19508969
NCBI chr 4:12,039,355...12,090,020
Ensembl chr 4:12,039,363...12,090,020
G
Tnf
tumor necrosis factor
severity
ISO
protein:increased expression:serum (human) associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
RGD
PMID:19695831 PMID:32626927
RGD:14995448 , RGD:401959337
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20353583
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Trpm7
transient receptor potential cation channel, subfamily M, member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25150141
NCBI chr 2:126,633,478...126,718,181
Ensembl chr 2:126,633,485...126,718,150
G
Tug1
taurine upregulated gene 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:37582412
NCBI chr11:3,589,313...3,599,021
Ensembl chr11:3,589,785...3,599,673
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:3,985,222...3,999,340
Ensembl chr19:3,985,186...3,999,340
G
Vash1
vasohibin 1
treatment
ISO
associated with Hepatitis C, Chronic; protein:increased expression:liver
RGD
PMID:24390792 PMID:24390792
RGD:15003198 , RGD:15003198
NCBI chr12:86,725,474...86,742,462
Ensembl chr12:86,725,474...86,738,865
G
Vcam1
vascular cell adhesion molecule 1
ISO
associated with chronic intermittent hypoxia; mRNA, protein:increased expression:liver (rat)
RGD
PMID:32626927
RGD:401959337
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
severity
ISO IMP
associated with nonalcoholic fatty liver disease; DNA:SNP: :rs1544410(human)
RGD
PMID:30683615 PMID:30218108 PMID:23622244
RGD:14401752 , RGD:14402031 , RGD:14402027
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:platelet: associated with Hepatitis C, Chronic; protein:increased expression:liver
CTD RGD
PMID:11981751 PMID:18544126 PMID:26627607
RGD:15003200 , RGD:11528851
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vegfc
vascular endothelial growth factor C
ISO
protein:increased expression:liver:
RGD
PMID:18544126
RGD:15003200
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:26396155 PMID:32659284
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Vtn
vitronectin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26396155
NCBI chr11:78,389,946...78,393,151
Ensembl chr11:78,389,917...78,393,150
G
Wdr35
WD repeat domain 35
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:18472094
RGD:11553927
NCBI chr12:9,023,897...9,078,848
Ensembl chr12:9,023,892...9,078,847
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
susceptibility
ISO
associated with Human Viral Hepatitis;DNA:missense mutation:cds:p.R399Q (rs25487) (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human)
RGD
PMID:24018491 PMID:29935355 PMID:23454624
RGD:14985244 , RGD:15036797 , RGD:15036794
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
susceptibility
ISO
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human)
RGD
PMID:29779728 PMID:23550892 PMID:11051375
RGD:14696777 , RGD:15042864 , RGD:15042858
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Bcl2
B cell leukemia/lymphoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
C3
complement component 3
ISO
RGD
PMID:9176087
RGD:408418722
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:decreased expression:brain
RGD
PMID:16205370
RGD:6483345
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
G
Col3a1
collagen, type III, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Crp
C-reactive protein, pentraxin-related
severity
ISO
RGD
PMID:22441510
RGD:6482305
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20843640 PMID:29404441
RGD:14700873
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Ddr1
discoidin domain receptor family, member 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Ddr2
discoidin domain receptor family, member 2
disease_progression ameliorates
ISO
RGD
PMID:21199726 PMID:23409069
RGD:150429766 , RGD:150517731
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Fabp2
fatty acid binding protein 2, intestinal
onset
ISO
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset
RGD
PMID:16289894
RGD:1578455
NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
susceptibility
ISO
DNA:SNP:intron 8:84435G>A (human)
RGD
PMID:19428381
RGD:402463950
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Il18bp
interleukin 18 binding protein
ISO
protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23274713 PMID:21236309
RGD:597538491
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Jak2
Janus kinase 2
ISO
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver
RGD
PMID:24619965
RGD:10403061
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Lep
leptin
IDA
DNA:hypomethylation:promoter (human)
RGD
PMID:29912265
RGD:21201248
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Mboat7
membrane bound O-acyltransferase domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr 7:3,680,788...3,696,188
Ensembl chr 7:3,680,788...3,696,522
G
Mir122
microRNA 122
ISO
miRNA:decreased expression:liver
RGD
PMID:28987423
RGD:14401600
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir141
microRNA 141
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948
G
Mir17
microRNA 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir193b
microRNA 193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,267,387...13,267,465
Ensembl chr16:13,267,387...13,267,465
G
Mir338
microRNA 338
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688
G
Mir421
microRNA 421
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:102,616,527...102,616,602
Ensembl chr X:102,616,527...102,616,602
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir483
microRNA 483
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,977,490...13,977,556
Ensembl chr16:13,977,490...13,977,556
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:7,114,641...7,114,736
Ensembl chr X:7,114,641...7,114,736
G
Mir93
microRNA 93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
G
Mmp13
matrix metallopeptidase 13
ISO
RGD
PMID:16286264
RGD:10043176
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19731237 PMID:23274713
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP: :677C>T(human)
RGD
PMID:25987440
RGD:14696749
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:19615318
RGD:7241800
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271 PMID:26482880
NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
DNA:polymorphism:promoter:
RGD
PMID:25987440
RGD:14696749
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Smad3
SMAD family member 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23274713 PMID:18180699
RGD:597830076
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Sod2
superoxide dismutase 2, mitochondrial
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human)
CTD RGD
PMID:19731237 PMID:26873981
RGD:11060603
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Tg
thyroglobulin
ISO
RGD
PMID:6883738
RGD:401976502
NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Timp1
tissue inhibitor of metalloproteinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tlr2
toll-like receptor 2
ISO
protein:increased expression:blood, neutrophil
RGD
PMID:18433921
RGD:5130706
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:18433921
RGD:5130706
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr9
toll-like receptor 9
ISO
protein:increased expression:blood, neutrophil
RGD
PMID:18433921
RGD:5130706
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr 8:70,525,574...70,532,716
Ensembl chr 8:70,525,574...70,532,716
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Aqp4
aquaporin 4
ISO
RGD
PMID:20680636
RGD:5148026
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Edar
ectodysplasin-A receptor
ISO
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy
ClinVar
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
NCBI chr10:58,436,602...58,511,518
Ensembl chr10:58,436,611...58,511,476
G
Fanci
Fanconi anemia, complementation group I
ISO
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy
ClinVar
PMID:15477547 PMID:15689359 PMID:16177225 PMID:16621917 PMID:17088268 PMID:17426723 PMID:17438011 PMID:17452773 PMID:17460694 PMID:17950645 PMID:17980715 PMID:18414213 PMID:18546365 PMID:18991199 PMID:19010300 PMID:19538466 PMID:20691285 PMID:21038416 PMID:21228398 PMID:21880868 PMID:22189570 PMID:22237560 PMID:23430898 PMID:23524600 PMID:23783014 PMID:24033266 PMID:24086434 PMID:25462018 PMID:25488682 PMID:25741868 PMID:26104464 PMID:26467025 PMID:27987238 PMID:28130605 PMID:28492532 PMID:28958595 PMID:30423451 PMID:30451971 PMID:30634555 PMID:31655921 PMID:33486010 PMID:35478072 More...
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
G
Polg
polymerase (DNA directed), gamma
susceptibility
ISO IAGP
DNA:mutations:cds: ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis | ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Alpers disease | ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Alpers progressive infantile poliodystrophy | ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis | ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4A (Alpers type) | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy ClinVar Annotator: match by term: Alpers Syndrome | ClinVar Annotator: match by term: Alpers-Huttenlocher Syndrome | ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy DNA:missense mutation:cds:p.P1073L (3218C>T) (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations:cds:
ClinVar CTD OMIM RGD
PMID:632821 PMID:1539879 PMID:1582434 PMID:1858914 PMID:2067633 PMID:2392416 PMID:2504279 PMID:2725645 PMID:7847370 PMID:9500334 PMID:9536098 PMID:11301032 PMID:11431686 PMID:11555352 PMID:11571332 PMID:11897778 PMID:12073019 PMID:12210792 PMID:12297582 PMID:12565911 PMID:12707443 PMID:12825077 PMID:12872260 PMID:12975295 PMID:14467368 PMID:14557557 PMID:14635118 PMID:14694057 PMID:14745080 PMID:15122711 PMID:15181170 PMID:15258572 PMID:15349879 PMID:15351195 PMID:15477547 PMID:15534189 PMID:15689359 PMID:15800909 PMID:15824347 PMID:15913923 PMID:15917273 PMID:15929042 PMID:16024923 PMID:16080118 PMID:16130100 PMID:16177225 PMID:16199547 PMID:16368709 PMID:16401742 PMID:16545482 PMID:16595552 PMID:16621917 PMID:16634032 PMID:16638794 PMID:16639411 PMID:16682683 PMID:16715201 PMID:16857757 PMID:16896309 PMID:16919951 PMID:16929381 PMID:16940310 PMID:16943369 PMID:16957900 PMID:17067213 PMID:17088268 PMID:17280874 PMID:17310215 PMID:17418573 PMID:17426723 PMID:17436221 PMID:17438011 PMID:17452231 PMID:17452773 PMID:17460694 PMID:17502560 PMID:17538929 PMID:17576681 PMID:17725985 PMID:17846414 PMID:17894835 PMID:17923349 PMID:17950645 PMID:17980715 PMID:18156159 PMID:18195149 PMID:18195151 PMID:18294203 PMID:18321754 PMID:18414213 PMID:18446447 PMID:18487244 PMID:18500570 PMID:18546343 PMID:18546365 PMID:18585914 PMID:18716558 PMID:18783964 PMID:18828154 PMID:18991199 PMID:19010300 PMID:19103152 PMID:19125351 PMID:19189930 PMID:19195941 PMID:19221117 PMID:19251978 PMID:19275594 PMID:19307547 PMID:19344718 PMID:19364868 PMID:19478085 PMID:19500334 PMID:19501198 PMID:19538466 PMID:19566497 PMID:19578034 PMID:19629138 PMID:19752458 PMID:19762913 PMID:19766516 PMID:19813183 PMID:19815814 PMID:19837034 PMID:19862739 PMID:19887119 PMID:20138553 PMID:20142534 PMID:20153822 PMID:20176107 PMID:20185557 PMID:20220442 PMID:20227526 PMID:20301791 PMID:20385918 PMID:20400524 PMID:20434700 PMID:20438629 PMID:20513108 PMID:20513922 PMID:20576279 PMID:20601675 PMID:20685647 PMID:20691285 PMID:20701905 PMID:20803511 PMID:20818383 PMID:20837861 PMID:20837862 PMID:20843780 PMID:20883824 PMID:20981092 PMID:21038416 PMID:21138766 PMID:21167499 PMID:21228000 PMID:21228398 PMID:21235791 PMID:21236670 PMID:21259344 PMID:21276947 PMID:21282586 PMID:21301859 PMID:21305355 PMID:21357833 PMID:21447491 PMID:21455106 PMID:21484424 PMID:21515089 PMID:21550804 PMID:21647632 PMID:21654874 PMID:21670405 PMID:21686371 PMID:21696159 PMID:21704543 PMID:21824913 PMID:21856450 PMID:21880868 PMID:21953457 PMID:21956653 PMID:21993618 PMID:22000311 PMID:22006280 PMID:22084276 PMID:22114710 PMID:22166854 PMID:22189570 PMID:22215559 PMID:22237560 PMID:22277967 PMID:22334187 PMID:22342071 PMID:22357363 PMID:22377773 PMID:22470557 PMID:22494076 PMID:22537151 PMID:22552686 PMID:22616202 PMID:22647225 PMID:22711370 PMID:22727047 PMID:22778364 PMID:22805437 PMID:22863191 PMID:22931735 PMID:22933815 PMID:22980518 PMID:22987704 PMID:22995991 PMID:23066759 PMID:23077218 PMID:23084792 PMID:23208208 PMID:23212759 PMID:23248042 PMID:23250882 PMID:23251356 PMID:23299917 PMID:23324391 PMID:23419467 PMID:23426270 PMID:23430834 PMID:23430898 PMID:23446635 PMID:23446645 PMID:23448099 PMID:23524600 PMID:23545419 PMID:23596069 PMID:23665194 PMID:23719791 PMID:23783014 PMID:23804100 PMID:23808377 PMID:23811324 PMID:23830586 PMID:23836942 PMID:23873972 PMID:23921535 PMID:24033266 PMID:24086434 PMID:24091540 PMID:24099403 PMID:24122062 PMID:24194468 PMID:24259288 PMID:24265579 PMID:24266892 PMID:24272679 PMID:24288107 PMID:24331360 PMID:24398692 PMID:24508722 PMID:24642831 PMID:24725338 PMID:24841123 PMID:24986207 PMID:25025039 PMID:25065347 PMID:25118206 PMID:25129007 PMID:25160553 PMID:25193669 PMID:25203713 PMID:25281868 PMID:25286830 PMID:25340760 PMID:25356970 PMID:25412673 PMID:25429852 PMID:25462018 PMID:25466440 PMID:25488682 PMID:25497598 PMID:25525159 PMID:25585994 PMID:25638290 PMID:25660390 PMID:25713120 PMID:25724872 PMID:25741868 PMID:25741916 PMID:25742477 PMID:25771874 PMID:25850945 PMID:25852747 PMID:25914719 PMID:25940035 PMID:26050231 PMID:26077851 PMID:26095671 PMID:26104464 PMID:26132555 PMID:26169155 PMID:26224072 PMID:26337858 PMID:26341968 PMID:26357557 PMID:26467025 PMID:26468652 PMID:26554610 PMID:26557169 PMID:26607151 PMID:26640698 PMID:26735972 PMID:26742794 PMID:26755490 PMID:26942291 PMID:26942292 PMID:26968897 PMID:27016405 PMID:27101133 PMID:27111573 PMID:27119776 PMID:27185166 PMID:27271921 PMID:27290639 PMID:27345795 PMID:27349602 PMID:27381400 PMID:27422324 PMID:27450679 PMID:27475922 PMID:27527004 PMID:27538604 PMID:27538665 PMID:27822509 PMID:27826120 PMID:27838477 PMID:27843123 PMID:27854218 PMID:27917773 PMID:27987238 PMID:28074849 PMID:28128857 PMID:28130605 PMID:28154168 PMID:28206745 PMID:28337550 PMID:28430993 PMID:28444220 PMID:28471437 PMID:28480171 PMID:28492532 PMID:28634151 PMID:28756246 PMID:28771251 PMID:28776642 PMID:28812649 PMID:28815208 PMID:28837072 PMID:28865037 PMID:28901595 PMID:28958595 PMID:29029963 PMID:29190809 PMID:29214156 PMID:29272804 PMID:29278894 PMID:29302508 PMID:29341116 PMID:29358615 PMID:29420653 PMID:29423831 PMID:29431110 PMID:29474836 PMID:29482223 PMID:29574624 PMID:29588995 PMID:29590070 PMID:29644085 PMID:29655203 PMID:29712893 PMID:29913018 PMID:29915382 PMID:29920680 PMID:29950568 PMID:29992832 PMID:29997391 PMID:30009132 PMID:30021052 PMID:30167885 PMID:30255931 PMID:30290626 PMID:30306720 PMID:30369941 PMID:30373890 PMID:30385167 PMID:30393377 PMID:30404819 PMID:30423451 PMID:30451971 PMID:30487145 PMID:30552426 PMID:30609409 PMID:30634555 PMID:30637288 PMID:30678510 PMID:30755392 PMID:30818899 PMID:30831263 PMID:30838265 PMID:30843307 PMID:30860128 PMID:30936349 PMID:30941926 PMID:30951992 PMID:31075681 PMID:31085725 PMID:31130284 PMID:31147703 PMID:31164858 PMID:31209396 PMID:31359948 PMID:31425757 PMID:31440721 PMID:31475037 PMID:31521625 PMID:31571979 PMID:31589614 PMID:31613174 PMID:31645654 PMID:31655921 PMID:31658717 PMID:31665838 PMID:31669236 PMID:31694722 PMID:31731261 PMID:31762033 PMID:31765440 PMID:31799610 PMID:31843010 PMID:31847883 PMID:31980526 PMID:31996268 PMID:32005694 PMID:32019516 PMID:32042919 PMID:32161153 PMID:32165824 PMID:32234506 PMID:32305867 PMID:32347949 PMID:32348839 PMID:32364361 PMID:32382377 PMID:32391929 PMID:32445240 PMID:32502631 PMID:32504279 PMID:32531456 PMID:32567010 PMID:32600829 PMID:32613234 PMID:32668698 PMID:32703289 PMID:32949115 PMID:32964447 PMID:33046616 PMID:33057194 PMID:33233646 PMID:33258288 PMID:33278787 PMID:33396418 PMID:33434755 PMID:33469851 PMID:33473333 PMID:33484326 PMID:33486010 PMID:33513296 PMID:33528536 PMID:33579567 PMID:33600046 PMID:33671400 PMID:33683010 PMID:33726816 PMID:33763395 PMID:33791913 PMID:33931544 PMID:33956154 PMID:34008892 PMID:34023347 PMID:34052969 PMID:34062649 PMID:34189666 PMID:34194468 PMID:34288125 PMID:34426522 PMID:34445196 PMID:34490615 PMID:34504347 PMID:34504726 PMID:34573359 PMID:34670123 PMID:34690748 PMID:34732400 PMID:34777884 PMID:34782754 PMID:34803902 PMID:34927673 PMID:35101151 PMID:35114397 PMID:35186329 PMID:35289132 PMID:35298342 PMID:35307828 PMID:35350396 PMID:35478072 PMID:35488641 PMID:35598585 PMID:35641312 PMID:35699875 PMID:35760101 PMID:35790454 PMID:35799515 PMID:35811315 PMID:35811324 PMID:35860755 PMID:35861376 PMID:35982159 PMID:36065636 PMID:36099812 PMID:36157077 PMID:36325100 PMID:36332611 PMID:36342673 PMID:36403551 PMID:36658419 PMID:36689859 PMID:36703223 PMID:36703500 PMID:36918699 PMID:36964972 PMID:36987741 PMID:37091313 PMID:37168916 PMID:37184518 PMID:37189790 PMID:37256495 PMID:37301908 PMID:37349538 PMID:37510298 PMID:38012111 PMID:38294884 PMID:38465286 PMID:38693247 PMID:38772265 PMID:38845467 PMID:39118480 PMID:39825153 PMID:15689359 PMID:20142534 PMID:16896309 PMID:22237560 More...
RGD:8694184 , RGD:15039298 , RGD:8694317 , RGD:8694284
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
Polrmt
polymerase (RNA) mitochondrial (DNA directed)
ISO
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy
ClinVar
PMID:25741868
NCBI chr10:79,571,951...79,582,436
Ensembl chr10:79,571,957...79,582,415
G
Ranbp2
RAN binding protein 2
ISO
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy
ClinVar
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
NCBI chr10:58,282,674...58,329,977
Ensembl chr10:58,282,742...58,330,178
G
Rlbp1
retinaldehyde binding protein 1
ISO
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy
ClinVar
PMID:2392416 PMID:11301032 PMID:21447491 PMID:25429852 PMID:28492532
NCBI chr 7:79,024,613...79,041,989
Ensembl chr 7:79,024,618...79,036,796
G
Ace
angiotensin I converting enzyme
ISO
protein:increased expression:serum (human)
RGD
PMID:21290180
RGD:25671452
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Itgb3
integrin beta 3
ISO
DNA:missense mutation: :p.L33P (human)
RGD
PMID:18685811
RGD:10755472
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:18685811
RGD:10755472
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
DNA:polymorphism:promoter:
RGD
PMID:18685811
RGD:10755472
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Ace
angiotensin I converting enzyme
ISO
associated with Polycystic Kidney, Autosomal Recessive;mRNA:increased expression:liver
RGD
PMID:20400910
RGD:2325215
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ifnl2
interferon lambda 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28394349
NCBI chr 7:28,208,209...28,209,957
Ensembl chr 7:28,208,261...28,209,880
G
Pkhd1
polycystic kidney and hepatic disease 1
IMP ISO
DNA:mutations:cds:c.7994T>C, p.(Leu2665Pro),c.8518C>T, p.(Arg2840Cys)(human)
RGD
PMID:30600684 PMID:30507656
RGD:14700919 , RGD:14700992
NCBI chr 1:20,128,003...20,688,306
Ensembl chr 1:20,128,003...20,688,288
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP: :-318C>T(human)
RGD
PMID:18049163
RGD:14398738
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Krt18
keratin 18
ISO
ClinVar Annotator: match by term: Cirrhosis, cryptogenic
ClinVar
PMID:9011570 PMID:12724528
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt8
keratin 8
ISO
ClinVar Annotator: match by term: Cirrhosis, cryptogenic
ClinVar
PMID:9011570 PMID:11372009 PMID:12724528 PMID:15235035 PMID:25741868 PMID:28492532 PMID:33116287 More...
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
1700025G04Rik
RIKEN cDNA 1700025G04 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:151,760,275...151,967,941
Ensembl chr 1:151,728,154...151,965,876
G
2510009E07Rik
RIKEN cDNA 2510009E07 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:21,467,795...21,513,415
Ensembl chr16:21,467,795...21,513,415
G
2610528J11Rik
RIKEN cDNA 2610528J11 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:118,384,207...118,387,422
Ensembl chr 4:118,384,196...118,387,425
G
4931406C07Rik
RIKEN cDNA 4931406C07 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:15,194,633...15,217,836
Ensembl chr 9:15,194,633...15,217,744
G
A2m
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Aadac
arylacetamide deacetylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:59,939,209...59,947,578
Ensembl chr 3:59,933,138...59,947,581
G
Aadat
aminoadipate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711
G
Abat
4-aminobutyrate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
G
Abca8a
ATP-binding cassette, sub-family A member 8a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:109,916,460...109,988,403
Ensembl chr11:109,916,460...109,986,804
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16182555 PMID:17072980
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcc2
ATP-binding cassette, sub-family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc5
ATP-binding cassette, sub-family C member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
G
Abcg1
ATP binding cassette subfamily G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
G
Abcg5
ATP binding cassette subfamily G member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
G
Abcg8
ATP binding cassette subfamily G member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:84,983,730...85,007,761
Ensembl chr17:84,983,730...85,007,761
G
Ablim3
actin binding LIM protein family, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:61,932,463...62,044,956
Ensembl chr18:61,932,463...62,044,895
G
Acat1
acetyl-Coenzyme A acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:53,491,822...53,521,650
Ensembl chr 9:53,491,822...53,521,682
G
Acbd4
acyl-Coenzyme A binding domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:102,992,524...103,003,026
Ensembl chr11:102,992,508...103,005,229
G
Ace
angiotensin I converting enzyme
severity
ISO
mRNA: increased expression:liver (rat) protein:increased activity:plasma (human) mRNA:increased expression:liver (rat)
RGD
PMID:19424597 PMID:8445218 PMID:23663763 PMID:24035938
RGD:25671449 , RGD:25671458 , RGD:25671457 , RGD:21408579
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
ISO
protein:increased expression:liver mRNA, protein:increased expression, increased activity:liver (rat)
RGD
PMID:19793108 PMID:16166274
RGD:2316776 , RGD:40818265
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Ache
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16496349
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:90,131,702...90,143,446
Ensembl chr 1:90,131,702...90,144,473
G
Acot9
acyl-CoA thioesterase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:154,045,439...154,080,650
Ensembl chr X:154,045,439...154,080,650
G
Acox2
acyl-Coenzyme A oxidase 2, branched chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262
G
Acp5
acid phosphatase 5, tartrate resistant
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088
G
Acta2
actin alpha 2, smooth muscle, aorta
ISO
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)
CTD RGD
PMID:26435214 PMID:26739621 PMID:29323718
RGD:38599216
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Actn1
actinin, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145
G
Acvr2a
activin receptor IIA
ISO
mRNA:decreased expression:liver
RGD
PMID:12706302
RGD:2325237
NCBI chr 2:48,704,121...48,793,276
Ensembl chr 2:48,704,121...48,793,281
G
Ada
adenosine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Adam17
a disintegrin and metallopeptidase domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:53,128,874...53,235,518
Ensembl chr19:53,128,874...53,235,830
G
Adgre1
adhesion G protein-coupled receptor E1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:57,665,650...57,790,527
Ensembl chr17:57,665,691...57,790,527
G
Adh1
alcohol dehydrogenase 1 (class I)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:9,618,173...9,648,195
Ensembl chr 1:9,618,173...9,650,898
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14724832
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
severity
IMP
RGD
PMID:29237572
RGD:24922203
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adm
adrenomedullin
ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15370692 PMID:16610064 PMID:16713642
RGD:1625319
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16783407
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
Adora3
adenosine A3 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:105,811,737...105,816,244
Ensembl chr 3:105,778,174...105,816,242
G
Adra1b
adrenergic receptor, alpha 1b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:43,665,432...43,792,076
Ensembl chr11:43,665,433...43,792,037
G
Adrb1
adrenergic receptor, beta 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
G
Adrb2
adrenergic receptor, beta 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Adrb3
adrenergic receptor, beta 3
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644
G
Aen
apoptosis enhancing nuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957
G
Afm
afamin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:90,666,808...90,701,403
Ensembl chr 5:90,666,791...90,701,402
G
Afp
alpha fetoprotein
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17072980 PMID:30346985
RGD:151665755
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
G
Ager
advanced glycosylation end product-specific receptor
treatment
ISO
RGD
PMID:26522143
RGD:597538456
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agfg1
ArfGAP with FG repeats 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:82,816,738...82,878,722
Ensembl chr 1:82,817,204...82,878,903
G
Agl
amylo-1,6-glucosidase, 4-alpha-glucanotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:116,533,648...116,601,815
Ensembl chr 3:116,533,648...116,601,815
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12667390
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Agtr1a
angiotensin II receptor, type 1a
treatment
IMP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12890498 PMID:25380136 PMID:24619965
RGD:10403061
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Ahnak
AHNAK nucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278
G
Aida
axin interactor, dorsalization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:183,078,604...183,105,356
Ensembl chr 1:183,078,134...183,106,331
G
Aif1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Akr1b1
aldo-keto reductase family 1 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1c18
aldo-keto reductase family 1, member C18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c19
aldo-keto reductase family 1, member C19
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:4,283,499...4,298,360
Ensembl chr13:4,278,699...4,302,842
G
Akt1
thymoma viral proto-oncogene 1
IEP
protein:increased phosphorylation:liver
RGD
PMID:31671832
RGD:407987423
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Aktip
AKT interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:91,834,267...91,862,122
Ensembl chr 8:91,838,412...91,926,604
G
Alb
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16642209 PMID:17963606 PMID:21163135 PMID:30346985
RGD:151665755
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:20,670,318...20,704,920
Ensembl chr19:20,670,317...20,704,926
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968 PMID:25380136
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr 6:90,527,751...90,576,153
Ensembl chr 6:90,463,409...90,577,185
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:83,320,386...83,370,008
Ensembl chr10:83,323,314...83,370,004
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Amacr
alpha-methylacyl-CoA racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr15:10,981,875...10,995,693
Ensembl chr15:10,981,842...10,996,712
G
Angpt1
angiopoietin 1
disease_progression
ISO
protein:increased expression:liver
RGD
PMID:17935226
RGD:1643338
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Angpt2
angiopoietin 2
ISO
mRNA, protein:increased expression:multiple organs (rat)
RGD
PMID:18978178
RGD:2314174
NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578
G
Angptl3
angiopoietin-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:98,919,191...98,926,429
Ensembl chr 4:98,919,191...98,934,348
G
Ano6
anoctamin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:95,688,724...95,873,353
Ensembl chr15:95,688,724...95,872,632
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
treatment
ISO
RGD
PMID:19054144
RGD:10401133
NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094
G
Anxa1
annexin A1
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:8755646
RGD:2306954
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Anxa3
annexin A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:96,941,257...96,993,825
Ensembl chr 5:96,941,198...96,993,825
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
G
Anxa5
annexin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Ap1s2
adaptor-related protein complex 1, sigma 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:162,691,427...162,716,662
Ensembl chr X:162,692,013...162,716,662
G
Ap3s1
adaptor-related protein complex 3, sigma 1 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:46,874,761...46,923,893
Ensembl chr18:46,874,943...46,923,893
G
Apaf1
apoptotic peptidase activating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:22,645,983...22,765,671
Ensembl chr 2:22,664,106...22,765,665
G
Apmap
adipocyte plasma membrane associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:150,425,000...150,450,487
Ensembl chr 2:150,425,000...150,450,487
G
Apoa1
apolipoprotein A-I
ISO
RGD
PMID:2123716
RGD:1599161
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apoa4
apolipoprotein A-IV
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Apobec1
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:122,554,755...122,580,068
Ensembl chr 6:122,554,751...122,579,403
G
Apol9a
apolipoprotein L 9a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:77,287,989...77,295,280
Ensembl chr15:77,287,989...77,295,335
G
Apon
apolipoprotein N
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:128,090,000...128,091,770
Ensembl chr10:128,089,965...128,091,765
G
App
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Appl1
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:26,640,943...26,692,567
Ensembl chr14:26,640,945...26,693,189
G
Aqp7
aquaporin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 4:41,033,074...41,048,237
Ensembl chr 4:41,033,074...41,048,139
G
Arg1
arginase, liver
ISO
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:11931836
RGD:1626298
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arg2
arginase type II
ISO
mRNA, protein:increased expression:liver
RGD
PMID:11931836
RGD:1626298
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Arhgap30
Rho GTPase activating protein 30
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:171,216,528...171,237,808
Ensembl chr 1:171,216,522...171,237,866
G
Arhgap9
Rho GTPase activating protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:127,157,829...127,165,816
Ensembl chr10:127,157,833...127,165,812
G
Arhgdib
Rho, GDP dissociation inhibitor beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897
G
Arl11
ADP-ribosylation factor-like 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:61,543,740...61,549,386
Ensembl chr14:61,547,202...61,549,385
G
Arl8a
ADP-ribosylation factor-like 8A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:135,074,572...135,084,007
Ensembl chr 1:135,074,562...135,084,007
G
Armcx1
armadillo repeat containing, X-linked 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:133,618,615...133,623,487
Ensembl chr X:133,618,712...133,622,666
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:145,051,066...145,064,996
Ensembl chr 5:145,051,025...145,067,515
G
Arrb2
arrestin, beta 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:aorta
CTD RGD
PMID:25380136 PMID:17256744
RGD:1625784
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Asah1
N-acylsphingosine amidohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810
G
Asns
asparagine synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Aspn
asporin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:49,697,919...49,721,041
Ensembl chr13:49,697,919...49,721,041
G
Ass1
argininosuccinate synthetase 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:19914391
RGD:4140452
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
G
Atp10d
ATPase, class V, type 10D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:72,360,672...72,456,114
Ensembl chr 5:72,360,672...72,456,118
G
Atp6v1d
ATPase, H+ transporting, lysosomal V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:78,889,756...78,908,810
Ensembl chr12:78,887,499...78,908,412
G
Atrn
attractin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:130,734,363...130,872,249
Ensembl chr 2:130,748,415...130,872,253
G
Axl
AXL receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
G
B2m
beta-2 microglobulin
ISO
protein:increased expression:urine
RGD
PMID:18777138
RGD:6482712
NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
G
B4galt5
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:167,140,364...167,191,155
Ensembl chr 2:167,140,364...167,191,103
G
B9d1
B9 protein domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:61,395,970...61,403,757
Ensembl chr11:61,395,970...61,403,757
G
Bak1
BCL2-antagonist/killer 1
ISO
mRNA:increased expression:liver
RGD
PMID:11232245
RGD:2315709
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
G
Bbox1
gamma-butyrobetaine hydroxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:110,094,401...110,145,158
Ensembl chr 2:110,093,042...110,144,905
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:24218972 PMID:17938867
RGD:10054116 , RGD:2293129
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2a1d
B cell leukemia/lymphoma 2 related protein A1d
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:88,605,341...88,613,903
Ensembl chr 9:88,605,338...88,613,967
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:74,896,384...75,020,753
Ensembl chr10:74,896,424...75,020,753
G
Bdh1
3-hydroxybutyrate dehydrogenase, type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr16:31,241,115...31,277,719
Ensembl chr16:31,241,098...31,277,719
G
Bgn
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:72,527,207...72,539,542
Ensembl chr X:72,527,208...72,539,539
G
Bicd2
BICD cargo adaptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:49,495,025...49,540,502
Ensembl chr13:49,495,061...49,540,502
G
Birc3
baculoviral IAP repeat-containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
Birc5
baculoviral IAP repeat-containing 5
ISO
RGD
PMID:17938867
RGD:2293129
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:44,127,685...44,134,909
Ensembl chr19:44,127,685...44,134,885
G
Blvra
biliverdin reductase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:126,912,549...126,939,004
Ensembl chr 2:126,912,585...126,939,004
G
Bmf
BCL2 modifying factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
G
Bmp4
bone morphogenetic protein 4
ISO
mRNA, protein:increased expression:liver
RGD
PMID:16447265
RGD:1643229
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Bmp7
bone morphogenetic protein 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17127702
NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
G
C1qa
complement component 1, q subcomponent, alpha polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
G
C1qb
complement component 1, q subcomponent, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
G
C1qc
complement component 1, q subcomponent, C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:136,617,115...136,620,225
Ensembl chr 4:136,617,115...136,620,376
G
C5ar1
complement component 5a receptor 1
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:15995705
RGD:1600592
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
C7
complement component 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:5,017,232...5,093,230
Ensembl chr15:5,018,244...5,093,222
G
C8g
complement component 8, gamma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:25,388,662...25,391,731
Ensembl chr 2:25,388,663...25,391,731
G
Camk2d
calcium/calmodulin-dependent protein kinase II, delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975
G
Capg
capping actin protein, gelsolin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:72,515,265...72,539,966
Ensembl chr 6:72,521,374...72,539,966
G
Car3
carbonic anhydrase 3
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Car5a
carbonic anhydrase 5a, mitochondrial
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:122,642,874...122,671,651
Ensembl chr 8:122,642,865...122,671,643
G
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp12
caspase 12
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:16092975
RGD:2311470
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp4
caspase 4, apoptosis-related cysteine peptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
G
Casp7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Cav1
caveolin 1, caveolae protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Ccdc126
coiled-coil domain containing 126
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:49,296,204...49,318,521
Ensembl chr 6:49,296,208...49,318,516
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism human gene in rat model
CTD RGD
PMID:15492853 PMID:19144177 PMID:28437891 PMID:15492853
RGD:2307001 , RGD:14995945 , RGD:8549576
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
treatment disease_progression severity
ISO IMP IGI IEP
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver
CTD RGD
PMID:25380136 PMID:22574195 PMID:25617348 PMID:20978355 PMID:20978355
RGD:14995337 , RGD:14995329 , RGD:14995328 , RGD:14995328
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccl6
C-C motif chemokine ligand 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:83,478,712...83,483,913
Ensembl chr11:83,478,708...83,483,913
G
Ccl7
C-C motif chemokine ligand 7
ISO
RGD
PMID:17719030
RGD:6483766
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
Ccn2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:19856102
RGD:2314367
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Ccn4
cellular communication network factor 4
ISO
RGD
PMID:24600972
RGD:10003105
NCBI chr15:66,763,337...66,795,050
Ensembl chr15:66,763,169...66,795,050
G
Ccna2
cyclin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccnb2
cyclin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
G
Ccng1
cyclin G1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
G
Ccr5
C-C motif chemokine receptor 5
treatment
IMP IEP
mRNA,protein:increased expression:liver
RGD
PMID:19603542 PMID:19603542
RGD:14401743 , RGD:14401743
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd163
CD163 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd200r1
CD200 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:44,586,141...44,615,341
Ensembl chr16:44,586,099...44,615,341
G
Cd200r2
Cd200 receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:44,687,460...44,736,203
Ensembl chr16:44,687,460...44,736,203
G
Cd24a
CD24a antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261
G
Cd276
CD276 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd38
CD38 antigen
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:16343077
RGD:2307239
NCBI chr 5:44,026,153...44,069,714
Ensembl chr 5:44,025,895...44,069,717
G
Cd48
CD48 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:171,508,989...171,532,825
Ensembl chr 1:171,509,577...171,532,826
G
Cd53
CD53 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:106,666,177...106,697,465
Ensembl chr 3:106,667,237...106,697,465
G
Cd5l
CD5 antigen-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380
G
Cd63
CD63 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:128,731,577...128,748,691
Ensembl chr10:128,736,858...128,748,691
G
Cd68
CD68 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
G
Cd7
CD7 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:120,927,573...120,930,304
Ensembl chr11:120,927,573...120,930,244
G
Cd74
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
G
Cd83
CD83 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
G
Cd86
CD86 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cdc42se1
CDC42 small effector 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:95,135,735...95,143,735
Ensembl chr 3:95,136,043...95,143,720
G
Cdh1
cadherin 1
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
G
Cdk1
cyclin dependent kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16534847
RGD:2289284
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
G
Cdk4
cyclin dependent kinase 4
ISO
RGD
PMID:16534847
RGD:2289284
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn2aipnl
CDKN2A interacting protein N-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:51,858,458...51,868,163
Ensembl chr11:51,858,488...51,868,161
G
Cdkn3
cyclin dependent kinase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126
G
Cdo1
cysteine dioxygenase 1, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr18:46,846,260...46,861,569
Ensembl chr18:46,846,260...46,861,462
G
Cebpd
CCAAT/enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Cela1
chymotrypsin-like elastase family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr15:100,572,303...100,585,801
Ensembl chr15:100,572,302...100,585,802
G
Celf2
CUGBP, Elav-like family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:6,544,505...7,401,345
Ensembl chr 2:6,544,505...7,514,374
G
Cemip2
cell migration inducing hyaluronidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:21,755,704...21,835,724
Ensembl chr19:21,755,706...21,835,724
G
Cerk
ceramide kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:86,023,302...86,070,537
Ensembl chr15:86,023,329...86,070,342
G
Ces2h
carboxylesterase 2H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
G
Ces3b
carboxylesterase 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 8:105,810,365...105,820,561
Ensembl chr 8:105,810,385...105,820,561
G
Cfd
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
G
Cfp
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:20,791,693...20,797,794
Ensembl chr X:20,791,693...20,797,794
G
Chsy1
chondroitin sulfate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:65,759,240...65,823,546
Ensembl chr 7:65,759,263...65,823,546
G
Cidea
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:67,476,634...67,500,864
Ensembl chr18:67,476,674...67,500,855
G
Cklf
chemokine-like factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:104,977,493...104,992,642
Ensembl chr 8:104,977,493...104,991,570
G
Clec4a1
C-type lectin domain family 4, member a1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:122,898,807...122,911,578
Ensembl chr 6:122,898,807...122,911,578
G
Clec4a3
C-type lectin domain family 4, member a3
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:122,929,474...122,946,837
Ensembl chr 6:122,929,474...122,946,834
G
Clec4f
C-type lectin domain family 4, member f
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:83,621,524...83,633,098
Ensembl chr 6:83,621,524...83,633,169
G
Clic1
chloride intracellular channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:35,269,219...35,277,695
Ensembl chr17:35,268,942...35,277,725
G
Clp1
CLP1, cleavage and polyadenylation factor I subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:84,553,466...84,557,631
Ensembl chr 2:84,552,448...84,557,694
G
Cmtm3
CKLF-like MARVEL transmembrane domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:105,065,993...105,074,304
Ensembl chr 8:105,066,042...105,074,304
G
Cndp1
carnosine dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:84,628,509...84,668,359
Ensembl chr18:84,628,634...84,668,220
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
G
Cnpy4
canopy FGF signaling regulator 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:138,185,768...138,192,180
Ensembl chr 5:138,185,747...138,192,180
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043671
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Col12a1
collagen, type XII, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:79,506,269...79,628,423
Ensembl chr 9:79,506,273...79,626,113
G
Col1a1
collagen, type I, alpha 1
treatment
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (rat)
CTD RGD
PMID:25380136 PMID:26435214 PMID:26739621 PMID:16009107 PMID:30346985 PMID:22706148 PMID:23958495 PMID:20818932 More...
RGD:1601595 , RGD:151665755 , RGD:8552768 , RGD:8552710 , RGD:5688339
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:7512265
RGD:7257544
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col3a1
collagen, type III, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11788567 PMID:25380136
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col4a1
collagen, type IV, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
G
Col4a2
collagen, type IV, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287
G
Col5a1
collagen, type V, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
G
Col5a2
collagen, type V, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442
G
Col6a1
collagen, type VI, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
G
Col6a2
collagen, type VI, alpha 2
ISO
Protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:7791542
RGD:1600938
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
G
Colec12
collectin sub-family member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644
G
Coq10a
coenzyme Q10A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:128,198,965...128,204,849
Ensembl chr10:128,198,969...128,204,866
G
Cotl1
coactosin like F-actin binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283
G
Cpq
carboxypeptidase Q
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698
G
Cps1
carbamoyl-phosphate synthetase 1
ISO
mRNA:decreased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15650968 PMID:17539997
RGD:2303515
NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
G
Creb1
cAMP responsive element binding protein 1
ISO
associated with Chemical and Drug Induced Liver Injury
RGD
PMID:27279449
RGD:401960093
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crot
carnitine O-octanoyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:decreased expression:serum:
RGD
PMID:21806828
RGD:9491781
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Crtap
cartilage associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:114,204,204...114,219,743
Ensembl chr 9:114,204,202...114,219,743
G
Cry1
cryptochrome circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:84,967,564...85,020,918
Ensembl chr10:84,967,564...85,020,928
G
Cryab
crystallin, alpha B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
G
Csad
cysteine sulfinic acid decarboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr15:102,085,432...102,112,685
Ensembl chr15:102,085,434...102,113,159
G
Csf1r
colony stimulating factor 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Csf3
colony stimulating factor 3 (granulocyte)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15661404
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Csgalnact1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:68,809,433...69,188,270
Ensembl chr 8:68,809,433...69,187,798
G
Ctla2a
cytotoxic T lymphocyte-associated protein 2 alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:61,081,969...61,084,439
Ensembl chr13:61,081,969...61,084,439
G
Ctse
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
G
Ctss
cathepsin S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
Ctsz
cathepsin Z
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:174,269,287...174,280,832
Ensembl chr 2:174,269,286...174,280,832
G
Cttnbp2nl
CTTNBP2 N-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:104,909,231...104,960,462
Ensembl chr 3:104,909,231...104,960,462
G
Cxadr
coxsackie virus and adenovirus receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:78,098,114...78,156,673
Ensembl chr16:78,098,377...78,156,662
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl13
C-X-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927
G
Cxcl16
C-X-C motif chemokine ligand 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:70,345,215...70,350,810
Ensembl chr11:70,344,809...70,350,810
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cyba
cytochrome b-245, alpha polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cybb
cytochrome b-245, beta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
G
Cygb
cytoglobin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16581302
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984
G
Cyp2c52-ps
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
treatment
ISO
RGD
PMID:15521018
RGD:15045602
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyria
CYFIP related Rac1 interactor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:12,312,136...12,430,966
Ensembl chr12:12,312,140...12,430,966
G
Cyrib
CYFIP related Rac1 interactor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:63,800,943...63,932,627
Ensembl chr15:63,800,946...63,932,327
G
Cystm1
cysteine-rich transmembrane module containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:36,481,677...36,536,032
Ensembl chr18:36,475,573...36,536,150
G
Dag1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr 9:108,082,060...108,141,176
Ensembl chr 9:108,081,833...108,141,157
G
Dao
D-amino acid oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:114,137,696...114,163,736
Ensembl chr 5:114,141,764...114,163,743
G
Dbh
dopamine beta hydroxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat)
RGD
PMID:18457899
RGD:5129683
NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212
G
Dbndd2
dysbindin domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:164,309,073...164,335,243
Ensembl chr 2:164,328,026...164,335,239
G
Dcxr
dicarbonyl L-xylulose reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:120,615,372...120,618,110
Ensembl chr11:120,616,225...120,618,107
G
Ddc
dopa decarboxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:18457899
RGD:5129683
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
G
Depdc7
DEP domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:104,552,129...104,573,202
Ensembl chr 2:104,552,129...104,573,223
G
Dhrs3
dehydrogenase/reductase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:144,618,712...144,654,214
Ensembl chr 4:144,619,397...144,654,779
G
Dhrs7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:5,901,030...5,947,648
Ensembl chr 2:5,900,926...5,947,603
G
Dio1
deiodinase, iodothyronine, type I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366
G
Dipk2a
divergent protein kinase domain 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:94,399,917...94,420,134
Ensembl chr 9:94,399,917...94,420,134
G
Dock10
dedicator of cytokinesis 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:80,478,785...80,736,482
Ensembl chr 1:80,478,790...80,736,244
G
Dock7
dedicator of cytokinesis 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:98,824,669...99,019,190
Ensembl chr 4:98,824,908...99,009,152
G
Dpp7
dipeptidylpeptidase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:25,242,302...25,246,365
Ensembl chr 2:25,242,288...25,246,371
G
Dpys
dihydropyrimidinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:39,631,881...39,720,866
Ensembl chr15:39,631,883...39,720,866
G
Dram1
DNA-damage regulated autophagy modulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:88,158,663...88,200,218
Ensembl chr10:88,158,666...88,214,942
G
Dus1l
dihydrouridine synthase 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:120,678,385...120,687,254
Ensembl chr11:120,680,027...120,687,229
G
Dusp16
dual specificity phosphatase 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:134,692,431...134,769,687
Ensembl chr 6:134,692,431...134,769,588
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
G
Dysf
dysferlin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:83,985,344...84,188,042
Ensembl chr 6:83,985,572...84,188,042
G
Ece1
endothelin converting enzyme 1
ISO
protein:increased expression:liver
RGD
PMID:16170464
RGD:7243952
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Ect2
ect2 oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12609069
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Eeig2
EEIG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:108,878,313...108,935,588
Ensembl chr 3:108,878,313...108,934,923
G
Egf
epidermal growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Eif4e3
eukaryotic translation initiation factor 4E member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:99,599,008...99,669,834
Ensembl chr 6:99,602,096...99,643,732
G
Elovl5
ELOVL fatty acid elongase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:77,824,647...77,891,801
Ensembl chr 9:77,824,646...77,891,801
G
Emb
embigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:117,357,109...117,410,951
Ensembl chr13:117,345,072...117,410,951
G
Emp1
epithelial membrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171
G
Enc1
ectodermal-neural cortex 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:97,377,613...97,389,548
Ensembl chr13:97,377,613...97,389,542
G
Enpep
glutamyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:129,062,826...129,126,398
Ensembl chr 3:129,062,824...129,126,369
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
treatment
ISO
protein:increased activity:serum: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17072980 PMID:17850827 PMID:20957682
RGD:9685426 , RGD:9685427
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
RGD
PMID:15651265
RGD:9685530
NCBI chr 2:25,285,886...25,291,335
Ensembl chr 2:25,285,886...25,291,333
G
Epb41l2
erythrocyte membrane protein band 4.1 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:25,235,680...25,399,413
Ensembl chr10:25,235,696...25,399,417
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557
G
Erap1
endoplasmic reticulum aminopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:74,787,692...74,841,321
Ensembl chr13:74,787,687...74,841,320
G
Ern1
endoplasmic reticulum to nucleus signalling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
Es2
esterase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
G
Extl1
exostosin-like glycosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:134,083,684...134,099,893
Ensembl chr 4:134,083,683...134,111,161
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
G
F2r
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
G
F5
coagulation factor V
treatment
ISO
RGD
PMID:17431769
RGD:7394781
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
Fabp2
fatty acid binding protein 2, intestinal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
G
Fabp7
fatty acid binding protein 7, brain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr10:57,661,019...57,664,546
Ensembl chr10:57,660,977...57,664,546
G
Fahd1
fumarylacetoacetate hydrolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:25,067,866...25,069,276
Ensembl chr17:25,067,866...25,069,338
G
Fam167b
family with sequence similarity 167, member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:129,470,608...129,472,373
Ensembl chr 4:129,470,608...129,472,342
G
Fam43a
family with sequence similarity 43, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:30,418,541...30,421,615
Ensembl chr16:30,418,541...30,421,615
G
Fam89a
family with sequence similarity 89, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:125,466,996...125,478,605
Ensembl chr 8:125,466,996...125,478,571
G
Fas
Fas cell surface death receptor
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30737368 PMID:17105443
RGD:2290284
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fat1
FAT atypical cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:45,386,137...45,505,294
Ensembl chr 8:45,388,484...45,505,294
G
Fbn1
fibrillin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
G
Fbxo9
f-box protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:77,988,781...78,016,347
Ensembl chr 9:77,988,781...78,016,347
G
Fcer1g
Fc receptor, IgE, high affinity I, gamma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:171,057,141...171,061,918
Ensembl chr 1:171,057,141...171,061,934
G
Fcgr1
Fc receptor, IgG, high affinity I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
G
Fcgr4
Fc receptor, IgG, low affinity IV
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
Fcnb
ficolin B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:27,966,491...27,974,921
Ensembl chr 2:27,966,390...27,974,897
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16116963
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fgfr1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:21543745
RGD:25440477
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Fgg
fibrinogen gamma chain
ISO
mRNA:increased expression
RGD
PMID:17054587
RGD:1599810
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
G
Fgl2
fibrinogen-like protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:21,577,671...21,583,384
Ensembl chr 5:21,577,640...21,583,372
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:132,701,406...132,729,204
Ensembl chr 4:132,701,406...132,729,221
G
Fhl1
four and a half LIM domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:55,776,569...55,838,704
Ensembl chr X:55,777,147...55,838,706
G
Fhl2
four and a half LIM domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144
G
Fkbp1a
FK506 binding protein 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:151,384,403...151,403,611
Ensembl chr 2:151,384,403...151,403,612
G
Fli1
Friend leukemia integration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:32,333,500...32,454,292
Ensembl chr 9:32,333,500...32,454,157
G
Flna
filamin, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
G
Fmnl1
formin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:103,061,401...103,089,727
Ensembl chr11:103,061,933...103,089,727
G
Fmnl2
formin-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:52,747,743...53,023,816
Ensembl chr 2:52,747,872...53,023,816
G
Fmo1
flavin containing monooxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
Fn1
fibronectin 1
treatment
ISO
mRNA:increased expression:liver: mRNA:altered expression:liver (rat)
RGD
PMID:19914391 PMID:15980055
RGD:4140452 , RGD:1625201
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Folr2
folate receptor beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:101,489,195...101,506,397
Ensembl chr 7:101,489,195...101,506,401
G
Fos
FBJ osteosarcoma oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxa2
forkhead box A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
G
Foxo1
forkhead box O1
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Fry
FRY microtubule binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:150,042,083...150,421,218
Ensembl chr 5:150,042,110...150,421,218
G
Fstl1
follistatin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:37,597,417...37,656,878
Ensembl chr16:37,597,235...37,656,876
G
Ftcd
formiminotransferase cyclodeaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:76,411,482...76,426,172
Ensembl chr10:76,411,482...76,426,172
G
Fxyd2
FXYD domain-containing ion transport regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:45,311,007...45,321,576
Ensembl chr 9:45,310,967...45,321,576
G
Fxyd5
FXYD domain-containing ion transport regulator 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:30,732,153...30,741,565
Ensembl chr 7:30,732,147...30,741,906
G
Fxyd6
FXYD domain-containing ion transport regulator 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:45,280,768...45,307,457
Ensembl chr 9:45,281,483...45,307,457
G
Fyn
Fyn proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
G
Fzd8
frizzled class receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:9,212,856...9,216,201
Ensembl chr18:9,212,163...9,218,136
G
G0s2
G0/G1 switch gene 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
Gab1
growth factor receptor bound protein 2-associated protein 1
IDA
protein:increased tyrosine phosphorylation: :
RGD
PMID:25617348
RGD:14995329
NCBI chr 8:81,491,060...81,607,151
Ensembl chr 8:81,491,063...81,607,148
G
Galc
galactosylceramidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:98,168,543...98,226,565
Ensembl chr12:98,168,553...98,225,718
G
Gask1b
golgi associated kinase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:79,791,795...79,853,585
Ensembl chr 3:79,791,840...79,853,587
G
Gbp2
guanylate binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:142,326,424...142,343,769
Ensembl chr 3:142,326,363...142,343,769
G
Gbp3
guanylate binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970
G
Gc
vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gcat
glycine C-acetyltransferase (2-amino-3-ketobutyrate-coenzyme A ligase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:78,915,074...78,926,731
Ensembl chr15:78,915,074...78,922,553 Ensembl chr15:78,915,074...78,922,553
G
Gchfr
GTP cyclohydrolase I feedback regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:118,998,269...119,002,870
Ensembl chr 2:118,998,254...119,002,871
G
Gck
glucokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1, core 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208
G
Get1
guided entry of tail-anchored proteins factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:95,946,600...95,959,052
Ensembl chr16:95,946,607...95,959,052
G
Gfap
glial fibrillary acidic protein
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gfra1
glial cell line derived neurotrophic factor family receptor alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:20,041,963...20,066,111
Ensembl chr 4:20,042,052...20,066,750
G
Ggta1
glycoprotein galactosyltransferase alpha 1, 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:35,290,191...35,354,393
Ensembl chr 2:35,290,191...35,353,243
G
Gh
growth hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15334695
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
G
Ghr
growth hormone receptor
ISO
mRNA, protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17072980 PMID:25380136 PMID:12679928
RGD:2307378
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Gja1
gap junction protein, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Gja4
gap junction protein, alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:127,205,213...127,207,832
Ensembl chr 4:127,205,214...127,207,832
G
Gk
glycerol kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:84,745,543...84,820,425
Ensembl chr X:84,745,543...84,820,425
G
Glipr1
GLI pathogenesis related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536
G
Gls
glutaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:52,202,608...52,274,168
Ensembl chr 1:52,202,607...52,272,391
G
Gls2
glutaminase 2 (liver, mitochondrial)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:128,030,504...128,045,873
Ensembl chr10:128,030,326...128,045,873
G
Glt8d1
glycosyltransferase 8 domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:30,723,137...30,733,948
Ensembl chr14:30,723,357...30,733,948
G
Gm13377
predicted gene 13377
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:21,049,620...21,144,493
Ensembl chr 2:21,049,619...21,146,765
G
Gm7030
predicted gene 7030
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317
G
Gmfg
glia maturation factor, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:28,136,894...28,147,655
Ensembl chr 7:28,136,872...28,147,658
G
Gna14
guanine nucleotide binding protein, alpha 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:16,413,031...16,590,706
Ensembl chr19:16,413,126...16,588,184
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566
G
Gngt2
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:95,733,045...95,736,557
Ensembl chr11:95,728,042...95,736,560
G
Gnpda1
glucosamine-6-phosphate deaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:38,460,588...38,472,052
Ensembl chr18:38,460,588...38,472,056
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:55,056,067...55,115,666
Ensembl chr19:55,055,700...55,115,670
G
Gpnmb
glycoprotein (transmembrane) nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
G
Gpr68
G protein-coupled receptor 68
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:100,842,941...100,874,457
Ensembl chr12:100,842,941...100,874,457
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17072980 PMID:22706148
RGD:8552768
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx8
glutathione peroxidase 8 (putative)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:113,179,287...113,182,944
Ensembl chr13:113,179,287...113,182,944
G
Grk2
G protein-coupled receptor kinase 2
ISO
protein:increased expression:aorta
RGD
PMID:17256744
RGD:1625784
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Grn
granulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
Gsn
gelsolin
ISO
mRNA, protein:increased expression CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:14574581
RGD:1599866
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Gsta3
glutathione S-transferase, alpha 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:21,310,837...21,335,885
Ensembl chr 1:21,310,813...21,335,885
G
Gsta4
glutathione S-transferase, alpha 4
treatment
ISO
RGD
PMID:23075396
RGD:9685568
NCBI chr 9:78,099,248...78,116,631
Ensembl chr 9:78,090,056...78,116,631
G
Gstm1
glutathione S-transferase, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstp3
glutathione S-transferase pi 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:4,107,470...4,109,587
Ensembl chr19:4,107,477...4,109,569
G
Gulo
gulonolactone (L-) oxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr14:66,224,235...66,246,703
Ensembl chr14:66,224,235...66,246,656
G
Gulp1
GULP, engulfment adaptor PTB domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:44,590,540...44,835,998
Ensembl chr 1:44,590,671...44,835,998
G
Gzma
granzyme A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-DMa
histocompatibility 2, class II, locus DMa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,338,667...34,358,075
Ensembl chr17:34,338,515...34,358,075
G
H2-DMb1
histocompatibility 2, class II, locus Mb1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,372,165...34,379,203
Ensembl chr17:34,372,046...34,379,204
G
H2-Ea
histocompatibility 2, class II antigen E alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
H2-Eb1
histocompatibility 2, class II antigen E beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-M3
histocompatibility 2, M region locus 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
G
Hagh
hydroxyacyl glutathione hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:25,056,863...25,083,424
Ensembl chr17:25,059,117...25,083,424
G
Hal
histidine ammonia lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hao1
hydroxyacid oxidase 1, liver
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:134,339,281...134,396,272
Ensembl chr 2:134,339,281...134,396,288
G
Hao2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
G
Hck
hemopoietic cell kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:152,950,388...152,993,361
Ensembl chr 2:152,950,388...152,993,361
G
Hells
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:38,913,282...38,958,914
Ensembl chr19:38,919,359...38,959,495
G
Hexim1
hexamethylene bis-acetamide inducible 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:103,007,151...103,010,551
Ensembl chr11:103,007,057...103,010,551
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10677585 PMID:12918455 PMID:15793283 PMID:16465399 PMID:16627068 PMID:17714472 PMID:18637143 More...
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hip1
huntingtin interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:135,435,350...135,574,167
Ensembl chr 5:135,435,385...135,573,974
G
Hjv
hemojuvelin BMP co-receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:96,432,479...96,436,532
Ensembl chr 3:96,432,488...96,436,526
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:16025519 PMID:16610050 PMID:21163135 PMID:25380136 PMID:19554654
RGD:4145305
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hopx
HOP homeobox
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:77,234,831...77,262,970
Ensembl chr 5:77,234,835...77,262,968
G
Hoxa3
homeobox A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:52,146,039...52,190,316
Ensembl chr 6:52,146,042...52,190,316
G
Hp
haptoglobin
ISO
protein:increased expression:serum protein:decreased expression:serum
RGD
PMID:16968543 PMID:21806828
RGD:1626367 , RGD:9491781
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hpcal1
hippocalcin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:17,740,810...17,841,943
Ensembl chr12:17,740,857...17,841,934
G
Hpgds
hematopoietic prostaglandin D synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:65,094,019...65,121,960
Ensembl chr 6:65,094,277...65,121,892
G
Hpse
heparanase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483 PMID:18458672
NCBI chr 5:100,827,350...100,867,582
Ensembl chr 5:100,827,350...100,867,582
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr10:127,826,800...127,843,517
Ensembl chr10:127,826,805...127,843,480
G
Htr2b
5-hydroxytryptamine (serotonin) receptor 2B
ISO
protein:increased expression:liver (rat)
RGD
PMID:16936262
RGD:9743846
NCBI chr 1:86,025,268...86,043,960
Ensembl chr 1:86,026,748...86,039,692
G
Hykk
hydroxylysine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:54,824,574...54,857,208
Ensembl chr 9:54,824,567...54,857,208
G
Icam2
intercellular adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:106,268,482...106,278,948
Ensembl chr11:106,268,482...106,278,901
G
Id2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17127702
NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
G
Id4
inhibitor of DNA binding 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
G
Ido1
indoleamine 2,3-dioxygenase 1
severity
IEP IMP
protein:increased expression:serum (mouse)
RGD
PMID:28465467 PMID:28465467
RGD:39939037 , RGD:39939037
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Idua
iduronidase, alpha-L
ISO
protein:increased expression:liver
RGD
PMID:6875476
RGD:12910840
NCBI chr 5:108,808,197...108,833,312
Ensembl chr 5:108,808,197...108,832,423
G
Ifi204
interferon activated gene 204
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:173,574,859...173,594,606
Ensembl chr 1:173,574,859...173,594,509
G
Ifi27l2b
interferon, alpha-inducible protein 27 like 2B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:103,417,157...103,423,482
Ensembl chr12:103,417,157...103,423,482
G
Ifi35
interferon-induced protein 35
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524
G
Ifitm1
interferon induced transmembrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:140,547,342...140,549,740
Ensembl chr 7:140,547,134...140,549,738
G
Ifna1
interferon alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12898905 PMID:14512876 PMID:16027843
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
G
Ifna2
interferon alpha 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12649538
NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149
G
Ifng
interferon gamma
ISO IEP
CTD Direct Evidence: therapeutic protein:increased expression:serum (mouse)
CTD RGD
PMID:12389079 PMID:15996030 PMID:16953842 PMID:17347453 PMID:28465467
RGD:39939037
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ifngr1
interferon gamma receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Ifrd1
interferon-related developmental regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:40,253,128...40,273,184
Ensembl chr12:40,251,566...40,298,503
G
Igf1
insulin-like growth factor 1
treatment
ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver:
CTD RGD
PMID:15591519 PMID:15745444 PMID:16434425 PMID:20198635 PMID:12800242
RGD:2317647 , RGD:12904923 , RGD:10045984
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
protein:increased expression:liver:
RGD
PMID:12800242
RGD:10045984
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891
G
Igf2r
insulin-like growth factor 2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Igfbp2
insulin-like growth factor binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Igfbp7
insulin-like growth factor binding protein 7
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:25691930
RGD:401976485
NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888
G
Igsf6
immunoglobulin superfamily, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:120,663,290...120,673,753
Ensembl chr 7:120,663,290...120,673,795
G
Ikbkg
inhibitor of kappaB kinase gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12632514 PMID:15362042 PMID:16097045 PMID:16126171 PMID:16539848 PMID:16552806 PMID:16609999 PMID:16688825 PMID:18251166 PMID:23980370 PMID:24993843 More...
RGD:7364982 , RGD:11049490
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il17a
interleukin 17A
treatment
IEP ISO
protein:increased expression:liver, serum (mouse)
RGD
PMID:28465467 PMID:30346985
RGD:39939037 , RGD:151665755
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il17ra
interleukin 17 receptor A
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr 6:120,440,143...120,460,692
Ensembl chr 6:120,440,208...120,464,520
G
Il17rc
interleukin 17 receptor C
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr 6:113,448,416...113,460,124
Ensembl chr 6:113,448,388...113,460,101
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18bp
interleukin 18 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il1b
interleukin 1 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16085334 PMID:24383550
RGD:10450610
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il2rb
interleukin 2 receptor, beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:78,363,456...78,396,569
Ensembl chr15:78,363,456...78,379,471
G
Il2rg
interleukin 2 receptor, gamma chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:100,307,991...100,311,861
Ensembl chr X:100,307,984...100,311,861
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il4
interleukin 4
IEP
protein:decreased expression:serum (mouse)
RGD
PMID:28465467
RGD:39939037
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
treatment
ISO IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:24383550 PMID:30346985 PMID:28465467
RGD:10450610 , RGD:151665755 , RGD:39939037
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
G
Ilk
integrin linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16941698
NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
G
Inhbc
inhibin beta-C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:127,192,191...127,206,417
Ensembl chr10:127,192,191...127,206,300
G
Inhbe
inhibin beta-E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Inmt
indolethylamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028
G
Inpp5d
inositol polyphosphate-5-phosphatase D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229
G
Inppl1
inositol polyphosphate phosphatase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:101,471,839...101,487,419
Ensembl chr 7:101,471,839...101,487,436
G
Ins2
insulin II
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26806094
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Insig2
insulin induced gene 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:121,232,082...121,260,391
Ensembl chr 1:121,232,082...121,260,318
G
Iqgap1
IQ motif containing GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:80,361,331...80,453,288
Ensembl chr 7:80,361,331...80,475,722
G
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:121,463,097...121,483,433
Ensembl chr 8:121,463,097...121,483,433
G
Isg20
interferon-stimulated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:78,561,136...78,570,144
Ensembl chr 7:78,563,172...78,570,144
G
Isyna1
myo-inositol 1-phosphate synthase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:71,047,131...71,049,940
Ensembl chr 8:71,047,023...71,049,940
G
Itga2b
integrin alpha 2b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
G
Itgal
integrin alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:126,895,404...126,934,309
Ensembl chr 7:126,895,432...126,934,310
G
Itgb1
integrin beta 1 (fibronectin receptor beta)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
G
Itgb2
integrin beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Itgb3
integrin beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Itgb6
integrin beta 6
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18221819 PMID:18538673
RGD:2302244
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
G
Ivd
isovaleryl coenzyme A dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:118,692,475...118,713,388
Ensembl chr 2:118,692,435...118,713,390
G
Iyd
iodotyrosine deiodinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
G
Jak2
Janus kinase 2
IDA ISO
protein:increased expression, increased tyrosine phosphorylation:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:24619965
RGD:10403061
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jdp2
Jun dimerization protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:85,645,190...85,686,652
Ensembl chr12:85,645,801...85,686,652
G
Kank1
KN motif and ankyrin repeat domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:25,214,146...25,411,861
Ensembl chr19:25,214,339...25,411,860
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:142,510,563...142,517,340
Ensembl chr 6:142,510,563...142,517,340
G
Kcnn4
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
exacerbates
IMP ISO
mRNA:increased expression:liver (rat)
RGD
PMID:27354175 PMID:27354175
RGD:329955558 , RGD:329955558
NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115
G
Klf6
Kruppel-like transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393
G
Kmo
kynurenine 3-monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:175,459,759...175,488,419
Ensembl chr 1:175,447,947...175,489,682
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18054572
NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828
G
Krt18
keratin 18
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver, plasma membrane (rat)
CTD RGD
PMID:15999547 PMID:17072980 PMID:18395095 PMID:25380136 PMID:21138630
RGD:27226809
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt19
keratin 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
G
Krt8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Ktn1
kinectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:47,886,551...47,974,021
Ensembl chr14:47,885,905...47,977,351
G
Kynu
kynureninase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
G
L3hypdh
L-3-hydroxyproline dehydratase (trans-)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:72,114,745...72,132,206
Ensembl chr12:72,120,202...72,132,213
G
Laptm5
lysosomal-associated protein transmembrane 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:130,640,627...130,663,459
Ensembl chr 4:130,640,436...130,663,452
G
Lbh
limb-bud and heart
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:73,225,300...73,248,941
Ensembl chr17:73,225,300...73,248,942
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lcp1
lymphocyte cytosolic protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:75,368,570...75,468,282
Ensembl chr14:75,368,541...75,468,282
G
Lcp2
lymphocyte cytosolic protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:33,996,928...34,042,281
Ensembl chr11:33,996,920...34,042,295
G
Ldhb
lactate dehydrogenase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683
G
Lefty2
left-right determination factor 2
ameliorates
IEP
RGD
PMID:34887753
RGD:401794438
NCBI chr 1:180,720,673...180,726,672
Ensembl chr 1:180,720,673...180,726,668
G
Lep
leptin
disease_progression
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586293 PMID:16097051 PMID:29248466 PMID:19065677 PMID:20509998
RGD:5128713 , RGD:5128589
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
ISO
protein:increased expression:serum
RGD
PMID:23886859
RGD:10412036
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lgals1
lectin, galactose binding, soluble 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
G
Lgals2
lectin, galactose-binding, soluble 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:78,735,060...78,739,729
Ensembl chr15:78,735,060...78,739,729
G
Lgals3
lectin, galactose binding, soluble 3
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16549783 PMID:25380136 PMID:12646584 PMID:16549783
RGD:9685223 , RGD:9685224
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lgalsl
galectin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:20,773,355...20,781,916
Ensembl chr11:20,773,576...20,781,056
G
Lgmn
legumain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:102,360,341...102,405,987
Ensembl chr12:102,360,343...102,406,072
G
Lhfpl6
LHFPL tetraspan subfamily member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:52,948,968...53,169,100
Ensembl chr 3:52,948,949...53,169,100
G
Limk2
LIM domain kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:3,293,297...3,359,238
Ensembl chr11:3,294,256...3,359,189
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:107,107,410...107,261,007
Ensembl chr10:107,107,547...107,257,335
G
Lmo2
LIM domain only 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:103,788,309...103,812,223
Ensembl chr 2:103,788,331...103,812,223
G
Lox
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Loxl2
lysyl oxidase-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:69,846,085...69,933,283
Ensembl chr14:69,846,517...69,933,283
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
G
Lpxn
leupaxin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:12,773,251...12,811,177
Ensembl chr19:12,773,557...12,811,171
G
Lrat
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280
G
Lrp6
low density lipoprotein receptor-related protein 6
IMP
RGD
PMID:18006602
RGD:4110127
NCBI chr 6:134,423,439...134,543,876
Ensembl chr 6:134,423,439...134,543,928
G
Lrrc28
leucine rich repeat containing 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:67,163,158...67,295,084
Ensembl chr 7:67,163,158...67,295,016
G
Lrrfip1
leucine rich repeat (in FLII) interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:90,924,652...91,056,666
Ensembl chr 1:90,926,459...91,056,666
G
Lta4h
leukotriene A4 hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:93,289,258...93,320,758
Ensembl chr10:93,289,273...93,320,737
G
Ltb
lymphotoxin B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:35,413,483...35,415,281
Ensembl chr17:35,413,415...35,415,296
G
Ltbp1
latent transforming growth factor beta binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:75,312,475...75,699,507
Ensembl chr17:75,312,563...75,699,507
G
Lum
lumican
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:97,401,363...97,408,565
Ensembl chr10:97,400,990...97,408,565
G
Lurap1l
leucine rich adaptor protein 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:80,828,923...80,872,538
Ensembl chr 4:80,828,883...80,873,865
G
Ly86
lymphocyte antigen 86
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:37,529,276...37,603,012
Ensembl chr13:37,529,184...37,603,012
G
Ly96
lymphocyte antigen 96
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:16,758,680...16,779,829
Ensembl chr 1:16,758,275...16,779,835
G
Magee1
MAGE family member E1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:104,163,984...104,167,567
Ensembl chr X:104,163,984...104,167,533
G
Malat1
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26435214
NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,853,602
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:27396351
RGD:13800880
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:27396351
RGD:13800880
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mas1
MAS1 oncogene
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19793108
RGD:2316776
NCBI chr17:13,056,981...13,087,037
Ensembl chr17:13,059,966...13,087,030
G
Mdh1
malate dehydrogenase 1, NAD (soluble)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:21,506,692...21,521,934
Ensembl chr11:21,506,692...21,522,367
G
Meox2
mesenchyme homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:37,158,539...37,229,533
Ensembl chr12:37,158,539...37,229,533
G
Met
met proto-oncogene
ISO
protein:decreased expression:liver (rat)
RGD
PMID:16958060
RGD:2317516
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Metrnl
meteorin, glial cell differentiation regulator-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:121,593,253...121,608,215
Ensembl chr11:121,592,370...121,607,132
G
Mfap4
microfibrillar-associated protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:61,376,257...61,379,536
Ensembl chr11:61,376,257...61,379,726
G
Mfn2
mitofusin 2
treatment
ISO
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:26882442 PMID:25369251
RGD:12910839 , RGD:13204798
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mgat5
mannoside acetylglucosaminyltransferase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23798564
NCBI chr 1:127,132,450...127,413,760
Ensembl chr 1:127,132,752...127,416,073
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
G
Mid1ip1
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish))
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:10,583,604...10,585,941
Ensembl chr X:10,581,252...10,585,929
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
protein:increased expression:hepatocyte
RGD
PMID:14706927
RGD:1642000
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mindy3
MINDY lysine 48 deubiquitinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:12,352,074...12,424,298
Ensembl chr 2:12,352,074...12,424,281
G
Mir122
microRNA 122
treatment
IMP
RGD
PMID:28987423
RGD:14401600
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir152
microRNA 152
treatment
IDA ISO
miRNA:decreased expression:liver
RGD
PMID:26257392 PMID:31258681
RGD:19165150 , RGD:19165153
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir17
microRNA 17
treatment
ISO
RGD
PMID:28177765
RGD:329403059
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir182
microRNA 182
ISO
associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr 6:30,165,917...30,165,991
Ensembl chr 6:30,165,917...30,165,991
G
Mir223
microRNA 223
IEP IMP
RNA:increased expression:liver RNA:increased expression:serum,liver
RGD
PMID:32003753 PMID:28646120 PMID:31295147
RGD:21408545 , RGD:21408574 , RGD:21408548
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir30a
microRNA 30a
treatment
ISO
RGD
PMID:29587268
RGD:35673290
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mis12
MIS12 kinetochore complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:70,910,394...70,918,197
Ensembl chr11:70,910,437...70,918,197
G
Mki67
antigen identified by monoclonal antibody Ki 67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mme
membrane metallo endopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16085334
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Mmp13
matrix metallopeptidase 13
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:17404313 PMID:10623612
RGD:10043161
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp15
matrix metallopeptidase 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:96,078,924...96,100,921
Ensembl chr 8:96,078,896...96,101,708
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12557150
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483 PMID:25380136
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:17094476
RGD:2325929
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp8
matrix metallopeptidase 8
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15057751
NCBI chr 9:7,558,430...7,568,487
Ensembl chr 9:7,558,457...7,568,486
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mob3a
MOB kinase activator 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:80,521,087...80,537,845
Ensembl chr10:80,521,087...80,537,811
G
Mro
maestro
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:73,992,465...74,014,405
Ensembl chr18:73,992,456...74,014,404
G
Msn
moesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:95,139,651...95,212,159
Ensembl chr X:95,139,648...95,212,158
G
mt-Cytb
cytochrome b, mitochondrial
ISO
protein:increased expression:mitochondrion, liver
RGD
PMID:2836123
RGD:2298972
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
G
Mt2
metallothionein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mtmr7
myotubularin related protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:41,003,184...41,088,210
Ensembl chr 8:41,004,136...41,087,840
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:25454463
RGD:10040998
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Mvp
major vault protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:126,586,036...126,613,729
Ensembl chr 7:126,586,032...126,613,793
G
Myadm
myeloid-associated differentiation marker
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:3,337,563...3,347,871
Ensembl chr 7:3,337,605...3,348,958
G
Myc
myelocytomatosis oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Myl9
myosin, light polypeptide 9, regulatory
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:156,617,373...156,623,578
Ensembl chr 2:156,617,340...156,623,578
G
Myo1c
myosin IC
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:75,541,345...75,565,450
Ensembl chr11:75,541,330...75,564,736
G
Myo1f
myosin IF
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:33,774,681...33,826,738
Ensembl chr17:33,774,681...33,826,738
G
Myo5a
myosin VA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:74,975,183...75,130,970
Ensembl chr 9:74,978,297...75,130,970
G
Myoc
myocilin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:162,466,719...162,477,263
Ensembl chr 1:162,466,724...162,477,262
G
Nagk
N-acetylglucosamine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:83,770,810...83,779,538
Ensembl chr 6:83,771,964...83,781,000
G
Nap1l5
nucleosome assembly protein 1-like 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:58,882,218...58,884,111
Ensembl chr 6:58,882,218...58,884,061
G
Nat8
N-acetyltransferase 8 (GCN5-related)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:85,807,369...85,813,839
Ensembl chr 6:85,807,370...85,809,064
G
Nbea
neurobeachin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:55,532,616...56,091,169
Ensembl chr 3:55,532,616...56,091,122
G
Nckap1l
NCK associated protein 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:103,362,219...103,411,288
Ensembl chr15:103,362,221...103,407,237
G
Ncor2
nuclear receptor co-repressor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:125,094,217...125,256,302
Ensembl chr 5:125,094,217...125,256,283
G
Ndrg1
N-myc downstream regulated gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489
G
Ndrg2
N-myc downstream regulated gene 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
G
Nectin2
nectin cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408
G
Nek6
NIMA (never in mitosis gene a)-related expressed kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:38,314,052...38,477,502
Ensembl chr 2:38,401,655...38,484,618
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23341968
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nfkbie
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:45,866,626...45,874,095
Ensembl chr17:45,866,629...45,874,095
G
Nfkbiz
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:55,631,740...55,659,018
Ensembl chr16:55,631,738...55,659,262
G
Nhsl3
NHS like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:129,113,371...129,155,194
Ensembl chr 4:129,113,371...129,155,197
G
Nid1
nidogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:13,612,252...13,686,849
Ensembl chr13:13,612,136...13,686,854
G
Nid2
nidogen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:19,801,325...19,861,855
Ensembl chr14:19,801,333...19,861,855
G
Nipal2
NIPA-like domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:34,572,942...34,679,739
Ensembl chr15:34,572,945...34,679,358
G
Nlrc5
NLR family, CARD domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
G
Nmi
N-myc (and STAT) interactor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:51,838,517...51,863,241
Ensembl chr 2:51,838,499...51,863,506
G
Noct
nocturnin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:51,131,868...51,159,075
Ensembl chr 3:51,131,868...51,159,065
G
Nos2
nitric oxide synthase 2, inducible
ISO
mRNA:increased expression:aorta CTD Direct Evidence: therapeutic mRNA:increased expression:heart
CTD RGD
PMID:18380797 PMID:10353629 PMID:10784593
RGD:2325278 , RGD:2325265
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
protein:decreased expression:spleen CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:18555214 PMID:17481668 PMID:17918268
RGD:2292140 , RGD:2292126
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nox4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
G
Npas2
neuronal PAS domain protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317
G
Npdc1
neural proliferation, differentiation and control 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:25,293,067...25,299,504
Ensembl chr 2:25,289,363...25,299,506
G
Nqo2
N-ribosyldihydronicotinamide quinone reductase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:34,148,642...34,172,448
Ensembl chr13:34,148,670...34,172,426
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment
ISO
mRNA:altered expression:liver (rat) associated with portal hypertension;mRNA;decreased expression;liver (rat)
RGD
PMID:27993716 PMID:15980055 PMID:24259407
RGD:14701034 , RGD:1625201 , RGD:15045598
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nrep
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Nrros
negative regulator of reactive oxygen species
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:31,961,603...31,984,412
Ensembl chr16:31,961,603...31,984,412
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:24,944,370...24,952,893
Ensembl chr 2:24,944,367...24,952,893
G
Nt5e
5' nucleotidase, ecto
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18263696
NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145
G
Nudt16
nudix hydrolase 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:105,006,531...105,010,332
Ensembl chr 9:105,006,102...105,009,023
G
Nupr1
nuclear protein transcription regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033
G
Oat
ornithine aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:132,159,204...132,178,127
Ensembl chr 7:132,159,207...132,178,127
G
Ogg1
8-oxoguanine DNA-glycosylase 1
treatment
ISO
RGD
PMID:23053977
RGD:8657403
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Olfml2b
olfactomedin-like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:170,472,101...170,510,356
Ensembl chr 1:170,472,101...170,510,358
G
Olfml3
olfactomedin-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317
G
Or51e2
olfactory receptor family 51 subfamily E member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
G
Osgin1
oxidative stress induced growth inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
G
Osm
oncostatin M
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17640959
NCBI chr11:4,186,831...4,191,027
Ensembl chr11:4,186,420...4,191,026
G
Otc
ornithine transcarbamylase
ISO
protein:decreased activity:liver (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:7865721
RGD:4144080
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Otub2
OTU domain, ubiquitin aldehyde binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:103,343,244...103,372,609
Ensembl chr12:103,354,941...103,372,609
G
Otulinl
OTU deubiquitinase with linear linkage specificity like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:27,655,154...27,681,630
Ensembl chr15:27,655,155...27,681,665
G
Palmd
palmdelphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:116,711,911...116,762,896
Ensembl chr 3:116,711,907...116,762,636
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:102,380,325...102,473,386
Ensembl chr 2:102,380,357...102,473,386
G
Paqr9
progestin and adipoQ receptor family member IX
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:95,441,687...95,450,075
Ensembl chr 9:95,441,710...95,450,076
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
G
Pcx
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pdgfa
platelet derived growth factor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:17382907
RGD:11080969
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15623374 PMID:18466260 PMID:15077122 PMID:18466260
RGD:2292206 , RGD:10449503
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pdxk
pyridoxal (pyridoxine, vitamin B6) kinase
ISO
protein:decreased expression:brain
RGD
PMID:3225873
RGD:2303021
NCBI chr10:78,272,581...78,300,782
Ensembl chr10:78,272,578...78,300,809
G
Pdzrn3
PDZ domain containing RING finger 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:101,126,568...101,354,858
Ensembl chr 6:101,126,570...101,354,858
G
Pea15a
proliferation and apoptosis adaptor protein 15A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:172,024,295...172,034,298
Ensembl chr 1:172,024,295...172,034,371
G
Pfkp
phosphofructokinase, platelet
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:6,629,910...6,699,096
Ensembl chr13:6,629,804...6,698,813
G
Pfn1
profilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:70,542,670...70,547,625
Ensembl chr11:70,542,676...70,545,470
G
Pgf
placental growth factor
disease_progression
ISO IMP
RGD
PMID:17935226 PMID:21520176
RGD:1643338 , RGD:6483607
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pkd2
polycystin 2, transient receptor potential cation channel
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685
G
Pklr
pyruvate kinase liver and red blood cell
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
G
Pla2g12a
phospholipase A2, group XIIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:129,672,255...129,689,474
Ensembl chr 3:129,672,255...129,689,474
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
ISO
protein:increased activity:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:17459512
RGD:1642445
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Plac8
placenta-specific 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:20035854
RGD:6484134
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:20035854 PMID:23018346 PMID:16958060
RGD:6484134 , RGD:7241553 , RGD:2317516
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pld4
phospholipase D family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:112,727,089...112,735,420
Ensembl chr12:112,727,089...112,735,424
G
Plek
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:16,921,206...16,958,718
Ensembl chr11:16,921,206...17,002,381
G
Plekhb1
pleckstrin homology domain containing, family B (evectins) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:100,291,922...100,311,601
Ensembl chr 7:100,292,099...100,311,621
G
Plekhh1
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:79,075,937...79,128,429
Ensembl chr12:79,075,937...79,128,429
G
Plg
plasminogen
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14716496
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Plin2
perilipin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297
G
Plin3
perilipin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:56,585,962...56,597,511
Ensembl chr17:56,584,476...56,599,873
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481
G
Plpp2
phospholipid phosphatase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:79,362,258...79,369,621
Ensembl chr10:79,362,264...79,369,630
G
Plscr1
phospholipid scramblase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,132,265...92,154,034
Ensembl chr 9:92,131,803...92,154,331
G
Plscr2
phospholipid scramblase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,157,655...92,179,805
Ensembl chr 9:92,157,655...92,179,805
G
Pltp
phospholipid transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:164,681,441...164,699,564
Ensembl chr 2:164,681,438...164,699,631
G
Pmepa1
prostate transmembrane protein, androgen induced 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:173,066,251...173,118,329
Ensembl chr 2:173,066,251...173,118,326
G
Pomc
pro-opiomelanocortin-alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16508911 PMID:16511523
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Pparg
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:18594976 PMID:22529699
RGD:2301874 , RGD:8553190
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppp1r18
protein phosphatase 1, regulatory subunit 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:36,176,483...36,186,488
Ensembl chr17:36,176,485...36,186,488
G
Ppp1r3b
protein phosphatase 1, regulatory subunit 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:35,842,847...35,855,293
Ensembl chr 8:35,842,893...35,855,293
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:36,709,131...36,714,004
Ensembl chr19:36,709,131...36,714,053
G
Praf2
PRA1 domain family 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:7,594,810...7,597,302
Ensembl chr X:7,594,678...7,597,303
G
Prkcb
protein kinase C, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
G
Prkcd
protein kinase C, delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
G
Prkn
parkin RBR E3 ubiquitin protein ligase
treatment
ISO
RGD
PMID:26882442
RGD:12910839
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
G
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349
G
Procr
protein C receptor, endothelial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391
G
Prodh
proline dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:17,889,593...17,907,147
Ensembl chr16:17,878,221...17,908,067
G
Prodh2
proline dehydrogenase (oxidase) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:30,193,011...30,212,830
Ensembl chr 7:30,193,047...30,212,827
G
Pros1
protein S (alpha)
ISO
mRNA, protein:decreased expression:liver, plasma
RGD
PMID:16995903
RGD:2300011
NCBI chr16:62,674,670...62,749,709
Ensembl chr16:62,674,670...62,749,709
G
Prr13
proline rich 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:102,367,605...102,371,241
Ensembl chr15:102,367,463...102,371,241
G
Prtg
protogenin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:72,714,556...72,824,589
Ensembl chr 9:72,714,156...72,824,573
G
Prune2
prune homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:16,933,033...17,201,322
Ensembl chr19:16,933,482...17,201,296
G
Psmb10
proteasome (prosome, macropain) subunit, beta type 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:106,662,360...106,665,024
Ensembl chr 8:106,662,367...106,665,076
G
Psmb8
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,417,169...34,420,428
Ensembl chr17:34,416,695...34,420,428
G
Psmb9
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
G
Psme2
proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:55,824,897...55,828,558
Ensembl chr14:55,824,898...55,828,570
G
Pstpip1
proline-serine-threonine phosphatase-interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:55,985,729...56,036,174
Ensembl chr 9:55,997,246...56,036,172
G
Ptafr
platelet-activating factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Pter
phosphotriesterase related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:12,928,828...13,008,265
Ensembl chr 2:12,928,852...13,008,266
G
Ptger2
prostaglandin E receptor 2 (subtype EP2)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17565644 PMID:18555214
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptk2
PTK2 protein tyrosine kinase 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:15378782
RGD:2292604
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:36,691,863...36,787,114
Ensembl chr 6:36,691,864...36,787,155
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26739621
NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305
G
Ptpn18
protein tyrosine phosphatase, non-receptor type 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:34,498,827...34,514,811
Ensembl chr 1:34,498,843...34,514,814
G
Ptprc
protein tyrosine phosphatase receptor type C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
G
Ptprd
protein tyrosine phosphatase receptor type D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:75,859,474...78,132,282
Ensembl chr 4:75,859,475...78,130,198
G
Ptpro
protein tyrosine phosphatase receptor type O
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:137,229,189...137,440,251
Ensembl chr 6:137,229,317...137,440,231
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:32,665,760...32,667,609
Ensembl chr 2:32,665,798...32,667,609
G
Ptrhd1
peptidyl-tRNA hydrolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:4,284,013...4,290,123
Ensembl chr12:4,284,027...4,289,950
G
Pxdn
peroxidasin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:29,986,641...30,067,657
Ensembl chr12:29,987,607...30,067,657
G
Pycard
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
G
Pycr1
pyrroline-5-carboxylate reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:120,527,591...120,534,602
Ensembl chr11:120,526,538...120,534,595
G
R3hdm2
R3H domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:127,216,201...127,335,253
Ensembl chr10:127,216,196...127,335,253
G
Rab30
RAB30, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:92,390,845...92,493,743
Ensembl chr 7:92,390,811...92,493,743
G
Rab31
RAB31, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:65,958,721...66,079,747
Ensembl chr17:65,958,724...66,079,747
G
Rab32
RAB32, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:10,420,783...10,433,951
Ensembl chr10:10,420,746...10,434,009
G
Rab40b
Rab40B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:121,246,951...121,279,080
Ensembl chr11:121,246,951...121,279,077
G
Rab8b
RAB8B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:66,750,891...66,826,987
Ensembl chr 9:66,750,946...66,826,969
G
Rabgap1l
RAB GTPase activating protein 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:160,046,744...160,621,046
Ensembl chr 1:160,046,744...160,620,781
G
Rac2
Rac family small GTPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:78,443,369...78,456,983
Ensembl chr15:78,443,367...78,456,983
G
Ramp1
receptor (calcitonin) activity modifying protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:91,107,544...91,152,918
Ensembl chr 1:91,107,544...91,152,918
G
Ramp2
receptor (calcitonin) activity modifying protein 2
ISO
RGD
PMID:16713642
RGD:1625319
NCBI chr11:101,137,160...101,139,076
Ensembl chr11:101,136,854...101,150,372
G
Rarres1
retinoic acid receptor responder (tazarotene induced) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:67,386,219...67,422,856
Ensembl chr 3:67,386,305...67,422,856
G
Rassf4
Ras association (RalGDS/AF-6) domain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:116,609,969...116,650,797
Ensembl chr 6:116,609,969...116,650,913
G
Rbl2
RB transcriptional corepressor like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
G
Rbm3
RNA binding motif (RNP1, RRM) protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:8,005,214...8,012,119
Ensembl chr X:8,005,214...8,012,119
G
Rbp4
retinol binding protein 4, plasma
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17337499
RGD:329845879
NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:105,216,293...105,229,664
Ensembl chr 2:105,216,636...105,229,664
G
Rcn2
reticulocalbin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166
G
Rcsd1
RCSD domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:165,476,503...165,537,632
Ensembl chr 1:165,474,085...165,537,326
G
Rdh10
retinol dehydrogenase 10 (all-trans)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:16,176,106...16,202,774
Ensembl chr 1:16,175,998...16,203,958
G
Rdh13
retinol dehydrogenase 13 (all-trans and 9-cis)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 7:4,428,664...4,474,279
Ensembl chr 7:4,427,769...4,448,648
G
Reck
reversion-inducing-cysteine-rich protein with kazal motifs
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:43,875,521...43,944,806
Ensembl chr 4:43,875,530...43,944,806
G
Reep5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:34,477,938...34,508,044
Ensembl chr18:34,477,938...34,507,123
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rell1
RELT-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:64,047,296...64,126,165
Ensembl chr 5:64,066,240...64,126,240
G
Reln
reelin
ISO
mRNA, protein:increased expression:liver, plasma (rat)
RGD
PMID:18449964
RGD:2317777
NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr X:20,413,980...20,428,328
Ensembl chr X:20,416,026...20,428,328
G
Rgs10
regulator of G-protein signalling 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:127,975,345...128,020,993
Ensembl chr 7:127,975,345...128,020,482
G
Rgs2
regulator of G-protein signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
G
Rgs3
regulator of G-protein signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:62,478,079...62,621,256
Ensembl chr 4:62,478,084...62,622,238
G
Rgs5
regulator of G-protein signaling 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:169,483,070...169,523,367
Ensembl chr 1:169,483,070...169,523,382
G
Rhoa
ras homolog family member A
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17596891
RGD:1642803
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rhoq
ras homolog family member Q
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:87,270,539...87,307,497
Ensembl chr17:87,270,510...87,307,497
G
Rida
reactive intermediate imine deaminase A homolog
treatment
ISO
RGD
PMID:23075396
RGD:9685568
NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
G
Rit1
Ras-like without CAAX 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:88,624,154...88,638,354
Ensembl chr 3:88,624,145...88,638,356
G
Rmdn2
regulator of microtubule dynamics 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:79,886,025...80,000,630
Ensembl chr17:79,919,292...80,000,621
G
Rmnd5b
required for meiotic nuclear division 5 homolog B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:51,514,500...51,526,723
Ensembl chr11:51,514,498...51,526,723
G
Rnase4
ribonuclease, RNase A family 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608
G
Rnasel
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967
G
Rnf39
ring finger protein 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:37,253,943...37,258,878
Ensembl chr17:37,253,810...37,258,878
G
Robo2
roundabout guidance receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,889,765
G
Rph3al
rabphilin 3A-like (without C2 domains)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr11:75,721,818...75,858,440
Ensembl chr11:75,721,825...75,829,255
G
Rsrp1
arginine/serine rich protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982
G
Rtn4
reticulon 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:29,642,898...29,694,414
Ensembl chr11:29,642,947...29,694,331
G
Rtp3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:110,814,003...110,818,781
Ensembl chr 9:110,814,003...110,819,651
G
Rxra
retinoid X receptor alpha
ISO
RGD
PMID:15566521
RGD:1643114
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
S100a10
S100 calcium binding protein A10 (calpactin)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950
G
S100a11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
G
S100a6
S100 calcium binding protein A6 (calcyclin)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:90,520,491...90,531,797
Ensembl chr 3:90,520,189...90,531,488
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:115,504,082...115,508,704
Ensembl chr 3:115,504,082...115,508,721
G
Samd11
sterile alpha motif domain containing 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:156,331,423...156,342,409
Ensembl chr 4:156,331,423...156,340,717
G
Sash3
SAM and SH3 domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:47,235,313...47,250,442
Ensembl chr X:47,235,313...47,250,442
G
Scd2
stearoyl-Coenzyme A desaturase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Sdr42e1
short chain dehydrogenase/reductase family 42E, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:118,388,138...118,400,428
Ensembl chr 8:118,388,138...118,400,428
G
Sds
serine dehydratase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:120,614,612...120,621,997
Ensembl chr 5:120,614,591...120,621,997
G
Sectm1b
secreted and transmembrane 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:120,944,248...120,954,377
Ensembl chr11:120,944,284...120,954,395
G
Selenbp2
selenium binding protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr 3:94,600,880...94,611,713
Ensembl chr 3:94,600,863...94,611,720
G
Selenom
selenoprotein M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:3,464,684...3,467,351
Ensembl chr11:3,464,684...3,467,351
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990
G
Selenow
selenoprotein W
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:15,651,133...15,656,296
Ensembl chr 7:15,651,133...15,656,327
G
Selp
selectin, platelet
ISO
protein:increased expression:bone marrow
RGD
PMID:19333758
RGD:2312308
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Sema6d
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:123,931,089...124,509,711
Ensembl chr 2:123,931,889...124,509,690
G
Senp2
SUMO/sentrin specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr16:21,828,182...21,868,019
Ensembl chr16:21,828,234...21,868,019
G
Serpina3k
serine (or cysteine) peptidase inhibitor, clade A, member 3K
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr12:104,304,745...104,311,998
Ensembl chr12:104,304,745...104,312,403
G
Serpina3m
serine (or cysteine) peptidase inhibitor, clade A, member 3M
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:104,353,424...104,360,518
Ensembl chr12:104,304,745...104,360,516
G
Serpina4-ps1
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:104,044,218...104,053,179
Ensembl chr12:104,046,908...104,052,983
G
Serpina6
serine (or cysteine) peptidase inhibitor, clade A, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:103,612,889...103,623,477
Ensembl chr12:103,612,889...103,623,471
G
Serpina7
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:137,979,998...137,985,985
Ensembl chr X:137,980,006...137,985,985
G
Serpinb9
serine (or cysteine) peptidase inhibitor, clade B, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:33,181,044...33,201,938
Ensembl chr13:33,187,233...33,201,940
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
associated with Inflammatory Bowel Diseases
RGD
PMID:16124052
RGD:1599330
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpinh1
serine (or cysteine) peptidase inhibitor, clade H, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18376398 PMID:25380136
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
G
Sez6
seizure related gene 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:77,821,403...77,869,874
Ensembl chr11:77,821,626...77,869,874
G
Sgcb
sarcoglycan, beta (dystrophin-associated glycoprotein)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:73,790,092...73,805,080
Ensembl chr 5:73,790,092...73,805,133
G
Sgk2
serum/glucocorticoid regulated kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:162,829,249...162,856,059
Ensembl chr 2:162,829,250...162,856,047
G
Sh3bgrl3
SH3 domain binding glutamic acid-rich protein-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:133,854,717...133,856,044
Ensembl chr 4:133,854,717...133,856,100
G
Shcbp1
Shc SH2-domain binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:4,785,976...4,829,549
Ensembl chr 8:4,785,976...4,829,567
G
Shisa3
shisa family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:67,765,226...67,771,330
Ensembl chr 5:67,765,225...67,780,895
G
Siglecf
sialic acid binding Ig-like lectin F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:43,000,496...43,008,899
Ensembl chr 7:43,000,765...43,008,955
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26435214
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Skap2
src family associated phosphoprotein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:51,836,145...51,989,529
Ensembl chr 6:51,834,402...51,989,529
G
Skil
SKI-like
ISO
RGD
PMID:19189315
RGD:2308901
NCBI chr 3:31,149,259...31,176,741
Ensembl chr 3:31,149,207...31,176,726
G
Sla
src-like adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:66,652,713...66,703,921
Ensembl chr15:66,652,668...66,703,678
G
Slamf9
SLAM family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:172,302,927...172,305,976
Ensembl chr 1:172,302,925...172,306,142
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc12a3
solute carrier family 12, member 3
ISO
protein:altered expression:kidney (rat)
RGD
PMID:15956070
RGD:1580587
NCBI chr 8:95,055,737...95,092,850
Ensembl chr 8:95,055,829...95,092,842
G
Slc15a3
solute carrier family 15, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:10,819,908...10,835,279
Ensembl chr19:10,817,091...10,836,726
G
Slc17a1
solute carrier family 17 (sodium phosphate), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr13:24,051,607...24,079,713
Ensembl chr13:24,051,733...24,079,713
G
Slc17a2
solute carrier family 17 (sodium phosphate), member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:23,990,924...24,009,174
Ensembl chr13:23,990,976...24,009,163
G
Slc19a2
solute carrier family 19 (thiamine transporter), member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:164,076,615...164,092,954
Ensembl chr 1:164,076,615...164,092,954
G
Slc20a1
solute carrier family 20, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:129,038,662...129,053,535
Ensembl chr 2:129,040,684...129,053,536
G
Slc22a23
solute carrier family 22, member 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:34,363,141...34,530,666
Ensembl chr13:34,363,141...34,529,165
G
Slc22a8
solute carrier family 22 (organic anion transporter), member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
G
Slc23a1
solute carrier family 23 (nucleobase transporters), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:35,747,657...35,762,900
Ensembl chr18:35,747,657...35,760,297
G
Slc25a13
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:6,041,218...6,217,304
Ensembl chr 6:6,041,218...6,217,173
G
Slc25a24
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:109,030,465...109,075,725
Ensembl chr 3:109,030,465...109,075,773
G
Slc25a30
solute carrier family 25, member 30
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:75,994,986...76,024,477
Ensembl chr14:75,997,557...76,024,477
G
Slc25a4
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
G
Slc37a4
solute carrier family 37 (glucose-6-phosphate transporter), member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 9:44,308,243...44,314,263
Ensembl chr 9:44,308,149...44,314,265
G
Slc39a6
solute carrier family 39 (metal ion transporter), member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:24,712,938...24,736,874
Ensembl chr18:24,712,938...24,736,874
G
Slc39a8
solute carrier family 39 (metal ion transporter), member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333
G
Slc43a2
solute carrier family 43, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:75,420,741...75,468,401
Ensembl chr11:75,422,520...75,468,401
G
Slc44a2
solute carrier family 44, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:21,232,015...21,266,324
Ensembl chr 9:21,231,994...21,266,324
G
Slc46a1
solute carrier family 46, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:78,356,527...78,362,771
Ensembl chr11:78,356,523...78,362,885
G
Slc4a4
solute carrier family 4 (anion exchanger), member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:88,941,717...89,387,515
Ensembl chr 5:89,034,345...89,387,512
G
Slc66a3
solute carrier family 66 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:17,038,649...17,050,385
Ensembl chr12:17,038,649...17,050,409
G
Slc7a1
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:148,264,220...148,336,714
Ensembl chr 5:148,264,220...148,336,714
G
Slfn2
schlafen 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:82,955,938...82,961,504
Ensembl chr11:82,955,938...82,961,504
G
Smad1
SMAD family member 1
ISO
RGD
PMID:16447265
RGD:1643229
NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147
G
Smad2
SMAD family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16570350
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Smad3
SMAD family member 3
treatment
ISO
RGD
PMID:30346985 PMID:25691930
RGD:151665755 , RGD:401976485
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smad4
SMAD family member 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16570350 PMID:19824107
RGD:12903949
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:109,961,129...110,069,773
Ensembl chr 9:109,946,776...110,069,246
G
Smc2
structural maintenance of chromosomes 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:52,438,966...52,488,365
Ensembl chr 4:52,439,243...52,488,260
G
Smc5
structural maintenance of chromosomes 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:23,183,817...23,251,286
Ensembl chr19:23,183,815...23,251,261
G
Smoc1
SPARC related modular calcium binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:81,073,582...81,233,188
Ensembl chr12:81,073,582...81,233,188
G
Smoc2
SPARC related modular calcium binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:14,499,768...14,625,052
Ensembl chr17:14,499,768...14,625,052
G
Snap23
synaptosomal-associated protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:120,398,137...120,436,829
Ensembl chr 2:120,398,152...120,431,736
G
Snap29
synaptosomal-associated protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:17,223,864...17,248,690
Ensembl chr16:17,223,850...17,248,691
G
Snx7
sorting nexin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:117,575,146...117,662,585
Ensembl chr 3:117,575,296...117,662,585
G
Soat1
sterol O-acyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:156,255,678...156,301,898
Ensembl chr 1:156,252,095...156,301,901
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
G
Sox4
SRY (sex determining region Y)-box 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver, fat cell
CTD RGD
PMID:18615449 PMID:25380136 PMID:18615449 PMID:8786698
RGD:2300030 , RGD:2300071
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Spin2c
spindlin family, member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr X:152,615,246...152,617,239
Ensembl chr X:152,615,221...152,617,239
G
Spp1
secreted phosphoprotein 1
IDA
RGD
PMID:16221502
RGD:1581332
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Spsb4
splA/ryanodine receptor domain and SOCS box containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:96,825,535...96,900,408
Ensembl chr 9:96,825,535...96,900,896
G
Sptan1
spectrin alpha, non-erythrocytic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:29,855,572...29,921,463
Ensembl chr 2:29,855,572...29,921,463
G
Srd5a1
steroid 5 alpha-reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561
G
Srebf1
sterol regulatory element binding transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srgn
serglycin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:62,329,612...62,363,224
Ensembl chr10:62,329,612...62,363,230
G
Sri
sorcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:8,096,078...8,119,314
Ensembl chr 5:8,096,078...8,119,379
G
Srr
serine racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:74,794,853...74,818,427
Ensembl chr11:74,797,185...74,816,774
G
St14
suppression of tumorigenicity 14 (colon carcinoma)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:30,999,886...31,043,138
Ensembl chr 9:31,000,698...31,043,149
G
Stac3
SH3 and cysteine rich domain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:127,337,505...127,344,692
Ensembl chr10:127,337,555...127,344,692
G
Stard13
StAR related lipid transfer domain containing 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:150,960,975...151,351,780
Ensembl chr 5:150,960,975...151,157,301
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stat5a
signal transducer and activator of transcription 5A
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
G
Stau2
staufen double-stranded RNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:16,299,027...16,591,228
Ensembl chr 1:16,298,898...16,590,336
G
Steap4
STEAP family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:8,010,472...8,032,213
Ensembl chr 5:8,010,457...8,032,213
G
Stk10
serine/threonine kinase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:32,483,266...32,574,595
Ensembl chr11:32,483,305...32,574,587
G
Sult1e1
sulfotransferase family 1E, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Sult2a1
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334
G
Synrg
synergin, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:83,855,217...83,935,404
Ensembl chr11:83,855,254...83,935,404
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
Tax1bp3
Tax1 (human T cell leukemia virus type I) binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:73,067,909...73,072,872
Ensembl chr11:73,067,909...73,073,988
G
Tbc1d9
TBC1 domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:83,891,981...83,999,569
Ensembl chr 8:83,891,981...83,999,563
G
Tcf20
transcription factor 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:82,692,648...82,872,304
Ensembl chr15:82,692,637...82,872,073
G
Tcf4
transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:69,476,500...69,821,038
Ensembl chr18:69,476,427...69,822,150
G
Tert
telomerase reverse transcriptase
ISO
protein:increased expression, increased localization:nucleus
RGD
PMID:20353272
RGD:11038673
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tes
testin LIM domain protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:17,065,148...17,105,824
Ensembl chr 6:17,065,148...17,105,827
G
Tfec
transcription factor EC
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:16,830,926...16,898,463
Ensembl chr 6:16,833,372...16,898,440
G
Tfpi2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919
G
Tgfb1
transforming growth factor, beta 1
treatment onset
ISO IEP
protein:increased expression:liver mRNA:increased expression:liver (mouse) associated with extrahepatic cholestasis associated with Chemical and Drug Induced Liver Injury CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12586293 PMID:15772939 PMID:16579972 PMID:26806094 PMID:27605418 PMID:16009107 PMID:28465467 PMID:27528511 PMID:30243650 PMID:28390311 PMID:30092114 More...
RGD:1601595 , RGD:39939037 , RGD:14995475 , RGD:14985234 , RGD:14985232 , RGD:14985231
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb3
transforming growth factor, beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:86,103,517...86,125,815
Ensembl chr12:86,103,519...86,125,815
G
Tgfbr1
transforming growth factor, beta receptor I
IMP ISO
protein:increased expression:liver
RGD
PMID:15723089 PMID:16009107
RGD:2302027 , RGD:1601595
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tgfbr2
transforming growth factor, beta receptor II
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:15942678 PMID:16627068 PMID:16627068 PMID:30346985
RGD:1579923 , RGD:151665755
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Th
tyrosine hydroxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat)
RGD
PMID:18457899
RGD:5129683
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Thbd
thrombomodulin
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:21112949
RGD:5685038
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Thpo
thrombopoietin
ISO
mRNA:decreased expression:liver
RGD
PMID:9794189
RGD:1580082
NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
G
Thyn1
thymocyte nuclear protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:26,910,950...26,918,632
Ensembl chr 9:26,911,006...26,918,632
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:128,041,496...128,063,450
Ensembl chr 7:128,041,501...128,063,441
G
Timp1
tissue inhibitor of metalloproteinase 1
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16507762 PMID:16718785 PMID:16762003 PMID:21163135 PMID:25380136 PMID:8707259 More...
RGD:2290364
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp2
tissue inhibitor of metalloproteinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tkfc
triokinase, FMN cyclase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:10,565,153...10,583,257
Ensembl chr19:10,565,155...10,583,018
G
Tlr2
toll-like receptor 2
treatment
ISO IEP
RGD
PMID:22683883 PMID:27601294
RGD:7241092 , RGD:18182936
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr3
toll-like receptor 3
IMP
RGD
PMID:27178735
RGD:21079415
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Tlr4
toll-like receptor 4
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:22683883 PMID:27601294
RGD:7241092 , RGD:18182936
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tm6sf1
transmembrane 6 superfamily member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:81,507,810...81,533,827
Ensembl chr 7:81,508,749...81,534,182
G
Tmbim1
transmembrane BAX inhibitor motif containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:74,327,406...74,343,495
Ensembl chr 1:74,327,406...74,344,781
G
Tmem106a
transmembrane protein 106A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:101,473,068...101,482,612
Ensembl chr11:101,473,068...101,482,614
G
Tmem165
transmembrane protein 165
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:76,331,727...76,357,091
Ensembl chr 5:76,331,727...76,357,092
G
Tmem178
transmembrane protein 178
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:81,252,061...81,309,245
Ensembl chr17:81,252,061...81,309,245
G
Tmem184b
transmembrane protein 184b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:79,244,884...79,287,503
Ensembl chr15:79,244,884...79,287,769
G
Tmem43
transmembrane protein 43
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:91,450,689...91,465,445
Ensembl chr 6:91,450,685...91,465,445
G
Tmem65
transmembrane protein 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:58,654,118...58,695,510
Ensembl chr15:58,654,118...58,695,487
G
Tmsb10
thymosin beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:72,934,330...72,935,731
Ensembl chr 6:72,934,330...72,935,731
G
Tnf
tumor necrosis factor
treatment
ISO IEP
mRNA:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16085334 PMID:24383550 PMID:28465467
RGD:10450610 , RGD:39939037
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip8
tumor necrosis factor, alpha-induced protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:50,112,494...50,226,296
Ensembl chr18:50,112,494...50,240,240
G
Tnfrsf12a
tumor necrosis factor receptor superfamily, member 12a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442
G
Tor4a
torsin family 4, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:25,082,732...25,086,825
Ensembl chr 2:25,082,978...25,086,898
G
Tpm1
tropomyosin 1, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:66,929,872...66,956,954
Ensembl chr 9:66,929,872...66,956,688
G
Tpm3
tropomyosin 3, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:89,979,958...90,008,209
Ensembl chr 3:89,979,956...90,008,209
G
Tpm4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:72,889,132...72,906,986
Ensembl chr 8:72,884,018...72,906,986
G
Trafd1
TRAF type zinc finger domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:121,509,788...121,524,543
Ensembl chr 5:121,509,788...121,523,695
G
Trak2
trafficking protein, kinesin binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:58,939,608...59,013,509
Ensembl chr 1:58,939,608...59,012,589
G
Trf
transferrin
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15650968 PMID:22464783
RGD:7244387
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
G
Trim24
tripartite motif-containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:37,846,816...37,945,380
Ensembl chr 6:37,847,746...37,943,231
G
Trim59
tripartite motif-containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:68,942,625...68,952,075
Ensembl chr 3:68,942,621...68,952,088
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043671
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205
G
Tspan8
tetraspanin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:115,652,722...115,685,798
Ensembl chr10:115,652,737...115,685,798
G
Tspo
translocator protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:83,447,774...83,458,404
Ensembl chr15:83,447,793...83,458,404
G
Tstd3
thiosulfate sulfurtransferase (rhodanese)-like domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:21,757,382...21,767,211
Ensembl chr 4:21,757,382...21,767,212
G
Ttc36
tetratricopeptide repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:44,710,697...44,714,248
Ensembl chr 9:44,710,694...44,714,369
G
Tubb6
tubulin, beta 6 class V
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:67,523,801...67,535,819
Ensembl chr18:67,523,787...67,535,819
G
Tusc3
tumor suppressor candidate 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:39,472,505...39,620,091
Ensembl chr 8:39,472,999...39,619,367
G
Tyrobp
TYRO protein tyrosine kinase binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:30,113,207...30,117,007
Ensembl chr 7:30,113,185...30,117,010
G
U2surp
U2 snRNP-associated SURP domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:95,338,947...95,394,049
Ensembl chr 9:95,338,951...95,394,049
G
Ubd
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Ugcg
UDP-glucose ceramide glucosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:59,189,452...59,222,833
Ensembl chr 4:59,189,257...59,222,833
G
Unc5cl
unc-5 family C-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:48,761,155...48,846,737
Ensembl chr17:48,761,929...48,846,742
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr19:3,985,222...3,999,340
Ensembl chr19:3,985,186...3,999,340
G
Vasp
vasodilator-stimulated phosphoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:18,990,854...19,005,779
Ensembl chr 7:18,990,854...19,005,742
G
Vav1
vav 1 oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18416461 PMID:18458672
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)
CTD RGD
PMID:25380136 PMID:29323718
RGD:38599216
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:121,471,782...121,502,020
Ensembl chr 9:121,471,782...121,502,020
G
Vopp1
vesicular, overexpressed in cancer, prosurvival protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:57,729,249...57,802,110
Ensembl chr 6:57,704,792...57,802,144
G
Vsir
V-set immunoregulatory receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:60,182,630...60,266,073
Ensembl chr10:60,182,630...60,208,463
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28527913 PMID:7531171
RGD:11079232
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wfdc2
WAP four-disulfide core domain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:164,404,635...164,410,430
Ensembl chr 2:164,404,333...164,410,430
G
Wfdc21
WAP four-disulfide core domain 21
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:83,637,766...83,643,472
Ensembl chr11:83,637,766...83,643,468
G
Wipf1
WAS/WASL interacting protein family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:73,259,954...73,359,831
Ensembl chr 2:73,259,954...73,360,078
G
Wls
wntless WNT ligand secretion mediator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:159,545,287...159,644,302
Ensembl chr 3:159,545,309...159,644,300
G
Xpnpep2
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:47,195,790...47,225,859
Ensembl chr X:47,197,602...47,225,858
G
Ybx1
Y box protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16012952
NCBI chr 4:119,134,524...119,153,462
Ensembl chr 4:119,135,178...119,151,801
G
Ypel3
yippee like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:126,376,135...126,379,682
Ensembl chr 7:126,376,127...126,379,686
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:135,937,233...135,963,495
Ensembl chr 5:135,937,263...135,963,470
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
G
Zbtb4
zinc finger and BTB domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:69,656,738...69,674,852
Ensembl chr11:69,656,738...69,674,849
G
Zdhhc13
zinc finger, DHHC domain containing 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:48,438,751...48,477,188
Ensembl chr 7:48,438,751...48,477,188
G
Zdhhc2
zinc finger, DHHC domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:40,876,526...40,946,178
Ensembl chr 8:40,876,856...40,963,309
G
Zeb2
zinc finger E-box binding homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:44,873,523...45,007,378
Ensembl chr 2:44,873,644...45,007,407
G
Zfp37
zinc finger protein 37
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:62,107,777...62,126,685
Ensembl chr 4:62,107,777...62,149,284
G
Zfyve16
zinc finger, FYVE domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:92,624,257...92,667,318
Ensembl chr13:92,623,616...92,667,376
G
Kctd1
potassium channel tetramerisation domain containing 1
ISO
ClinVar Annotator: match by term: SEN SYNDROME
ClinVar
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532
NCBI chr18:15,101,742...15,284,503
Ensembl chr18:15,101,742...15,284,503
G
Krt18
keratin 18
ISO
ClinVar Annotator: match by term: Cirrhosis, familial | ClinVar Annotator: match by term: Cirrhosis, noncryptogenic, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:9011570 PMID:12724528 PMID:25741868
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt8
keratin 8
ISO
ClinVar Annotator: match by term: Cirrhosis, familial | ClinVar Annotator: match by term: Cirrhosis, noncryptogenic, susceptibility to
ClinVar
PMID:9011570 PMID:12724528 PMID:25741868
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Tjp2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Familial primary biliary cirrhosis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr19:24,071,860...24,202,492
Ensembl chr19:24,071,869...24,202,394
G
Tulp3
TUB like protein 3
ISO
ClinVar Annotator: match by term: Hepatorenocardiac degenerative fibrosis
OMIM ClinVar
PMID:25741868 PMID:35397207
NCBI chr 6:128,298,103...128,332,833
Ensembl chr 6:128,298,124...128,332,814
G
Slc30a10
solute carrier family 30, member 10
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hypermanganesemia with dystonia, polycythemia, and cirrhosis | ClinVar Annotator: match by term: SLC30A10-related condition
CTD ClinVar OMIM
PMID:11040156 PMID:18392750 PMID:22341971 PMID:22341972 PMID:22926781 PMID:22934317 PMID:25741868 PMID:27117033 PMID:28492532 PMID:30272946 PMID:31594250 PMID:34315874 More...
NCBI chr 1:185,187,045...185,200,959
Ensembl chr 1:185,187,045...185,200,959
G
Utp4
UTP4 small subunit processome component
ISO
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis
ClinVar
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
NCBI chr 8:107,620,272...107,649,726
Ensembl chr 8:107,620,268...107,649,720
G
Abca1
ATP-binding cassette, sub-family A member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28660384
RGD:21203516
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
G
Abcb4
ATP-binding cassette, sub-family B member 4
treatment disease_progression
ISO IMP
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype, diplotype: : rs31658, rs31672,rs1149222(human)
CTD RGD
PMID:20040336 PMID:30682444 PMID:21209952 PMID:18671305
RGD:153297773 , RGD:14694982
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
G
Abcc2
ATP-binding cassette, sub-family member 2
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:15542527 PMID:15770136
RGD:14700810
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542527
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Ace
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver
RGD
PMID:19389807
RGD:2325226
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17532087
RGD:9685452
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Agt
angiotensinogen
ISO
protein:increased expression:plasma
RGD
PMID:17532087
RGD:9685452
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aqp4
aquaporin 4
ISO
RGD
PMID:20451280
RGD:5148030
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Car1
carbonic anhydrase 1
ISO
RGD
PMID:12806141
RGD:408425977
NCBI chr 3:14,831,274...14,873,425
Ensembl chr 3:14,831,276...14,873,428
G
Car2
carbonic anhydrase 2
ISO
RGD
PMID:12806141
RGD:408425977
NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver:
CTD RGD
PMID:12126966 PMID:15770052
RGD:14995336
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccn2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19371232
RGD:2314517
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Cd14
CD14 antigen
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd3d
CD3 antigen, delta polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 9:44,893,067...44,898,350
Ensembl chr 9:44,893,084...44,898,637
G
Cd68
CD68 antigen
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
G
Cd80
CD80 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:epithelial cell:
RGD
PMID:18456456
RGD:8662434
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cenpb
centromere protein B
ISO
RGD
PMID:8911074
RGD:27226708
NCBI chr 2:131,019,209...131,021,974
Ensembl chr 2:131,017,102...131,021,987
G
Clec16a
C-type lectin domain family 16, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr16:10,363,173...10,562,742
Ensembl chr16:10,363,203...10,562,742
G
Col1a1
collagen, type I, alpha 1
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Cpeb1
cytoplasmic polyadenylation element binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 7:80,996,774...81,105,207
Ensembl chr 7:80,996,774...81,105,213
G
Cpeb4
cytoplasmic polyadenylation element binding protein 4
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr11:31,820,911...31,885,635
Ensembl chr11:31,822,211...31,885,634
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility disease_progression no_association
ISO
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) (human) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNPs: :rs231775, rs3087243, rs231725 (human) DNA:SNP:CDS:49A>G(human)
RGD
PMID:10782900 PMID:16584111 PMID:21594562 PMID:17482523
RGD:2301998 , RGD:14398744 , RGD:14398743 , RGD:14398725
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21731723
RGD:26884357
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr5
C-X-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 9:44,423,084...44,437,741
Ensembl chr 9:44,423,084...44,473,174
G
Cygb
cytoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
G
Dag1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr 9:108,082,060...108,141,176
Ensembl chr 9:108,081,833...108,141,157
G
Dennd1b
DENN domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 1:138,891,447...139,103,781
Ensembl chr 1:138,891,173...139,106,698
G
Dnase1
deoxyribonuclease I
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr16:3,855,007...3,857,888
Ensembl chr16:3,854,806...3,857,888
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15651265 PMID:15651265
RGD:9685530
NCBI chr 2:25,285,886...25,291,335
Ensembl chr 2:25,285,886...25,291,333
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Foxp3
forkhead box P3
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:20132096
RGD:329970291
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:15713222
RGD:14401562
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
Hamp
hepcidin antimicrobial peptide
treatment
ISO
mRNA:decreased expression:liver
RGD
PMID:19652645 PMID:23704825
RGD:11041639 , RGD:11041732
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hhip
Hedgehog-interacting protein
ISO
mRNA:decreased expression:
RGD
PMID:18375471
RGD:11552599
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmox1
heme oxygenase 1
ISO
mRNA, protein:increased expression:liver, lung
RGD
PMID:12114196
RGD:625603
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Icam1
intercellular adhesion molecule 1
treatment
IMP ISO
associated with Graft vs Host Disease; protein:increased expression:serum:
RGD
PMID:10051478 PMID:11280567
RGD:11520783 , RGD:597000690
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifng
interferon gamma
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Il10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12a
interleukin 12a
susceptibility treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNP: :rs62270414(human) DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human)
CTD RGD
PMID:20639880 PMID:19458352 PMID:23433321 PMID:27175695
RGD:25440500 , RGD:25440498 , RGD:25440489
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
G
Il12b
interleukin 12b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il12rb1
interleukin 12 receptor, beta 1
susceptibility
IEP
RNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23910013
RGD:14700865
NCBI chr 8:71,261,005...71,276,186
Ensembl chr 8:71,261,093...71,274,068
G
Il1b
interleukin 1 beta
disease_progression
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:20442198
RGD:7829828
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
disease_progression
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
G
Jak2
Janus kinase 2
treatment
ISO
RGD
PMID:24619965
RGD:10403061
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Keap1
kelch-like ECH-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Krt18
keratin 18
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:26110613
RGD:18337483
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Krt7
keratin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21681009
NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
G
Lbr
lamin B receptor
ISO
RGD
PMID:8550049
RGD:9588625
NCBI chr 1:181,642,880...181,669,933
Ensembl chr 1:181,642,900...181,670,611
G
Lep
leptin
ISO
protein:decreased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
ISO
protein:increased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lox
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Loxl2
lysyl oxidase-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr14:69,846,085...69,933,283
Ensembl chr14:69,846,517...69,933,283
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
IAGP
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr11:103,110,590...103,158,227
Ensembl chr11:103,110,588...103,158,298
G
Mapk14
mitogen-activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mas1
MAS1 oncogene
ISO
RGD
PMID:17532087
RGD:9685452
NCBI chr17:13,056,981...13,087,037
Ensembl chr17:13,059,966...13,087,030
G
Met
met proto-oncogene
severity
IMP
RGD
PMID:19208365
RGD:14694826
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mir21a
microRNA 21a
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir223
microRNA 223
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mmel1
membrane metallo-endopeptidase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639879
NCBI chr 4:154,954,042...154,979,987
Ensembl chr 4:154,954,042...154,979,985
G
Mmp13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp3
matrix metallopeptidase 3
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:20056896
RGD:8552731
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Msn
moesin
ISO
protein:increased phosphorylation:liver, blood vessel:
RGD
PMID:16492715
RGD:2298879
NCBI chr X:95,139,651...95,212,159
Ensembl chr X:95,139,648...95,212,158
G
Muc2
mucin 2
ISO
RGD
PMID:18507686
RGD:2324885
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nos2
nitric oxide synthase 2, inducible
ISO
protein:increased expression, increased activity:brain (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:21903766
RGD:5509055
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:20132096
RGD:329970291
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
susceptibility
ISO
mRNA,protein:decreased expression:liver (human)
RGD
PMID:29968724
RGD:14928336
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
mRNA:altered expression:leukocyte, mononuclear
RGD
PMID:15635817
RGD:4892607
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nsa2
NSA2 ribosome biogenesis homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr13:97,265,935...97,274,434
Ensembl chr13:97,265,932...97,274,445
G
Nup62
nucleoporin 62
severity
ISO
RGD
PMID:12753810
RGD:9831196
NCBI chr 7:44,465,512...44,481,260
Ensembl chr 7:44,465,512...44,480,236
G
Pde5a
phosphodiesterase 5A, cGMP-specific
ISO
RGD
PMID:17610866
RGD:2314466
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:
RGD:6484526
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:30026087 PMID:21275501
RGD:407420272
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Ren1
renin 1 structural
ISO
protein:increased activity:plasma (rat)
RGD
PMID:22266601
RGD:6892690
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Rhoa
ras homolog family member A
ISO
mRNA, protein:increased expression:liver
RGD
PMID:16492715
RGD:2298879
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:16492715
RGD:2298879
NCBI chr12:16,944,808...17,038,275
Ensembl chr12:16,944,896...17,037,824
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:15769867
RGD:1642977
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
G
Sell
selectin, lymphocyte
ISO
protein:increased expression:serum:
RGD
PMID:11280567
RGD:597000690
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Slc4a2
solute carrier family 4 (anion exchanger), member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18188457
NCBI chr 5:24,628,834...24,645,945
Ensembl chr 5:24,628,835...24,645,948
G
Slc51a
solute carrier family 51, alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
G
Slc51b
solute carrier family 51, beta subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr 9:65,320,035...65,330,055
Ensembl chr 9:65,319,996...65,330,237
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
ISO
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr 6:141,470,080...141,515,903
Ensembl chr 6:141,470,094...141,515,903
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
protein:increased expression:serum
RGD
PMID:1682406
RGD:2317411
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Spib
Spi-B transcription factor (Spi-1/PU.1 related)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 7:44,175,419...44,181,511
Ensembl chr 7:44,175,417...44,181,495
G
Spint1
serine protease inhibitor, Kunitz type 1
IEP
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 2:119,067,841...119,079,995
Ensembl chr 2:119,067,843...119,080,008
G
Spint2
serine protease inhibitor, Kunitz type 2
IEP
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 7:28,955,755...28,981,484
Ensembl chr 7:28,955,748...28,981,337
G
Stat4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism associated with Crohn���s disease; DNA:SNP:intron: (rs7574865) (human) DNA:SNP: intron: (rs7574865) (human) DNA:SNPs:3'utr: (rs7574865, rs8179673, rs10181656) (human) DNA:SNPs, haplotypes:multiple
CTD RGD
PMID:21399635 PMID:26084578 PMID:28395724 PMID:24648611 PMID:24648611
RGD:25671421 , RGD:25671416 , RGD:25671415 , RGD:25671415
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tjp2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Primary biliary cirrhosis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr19:24,071,860...24,202,492
Ensembl chr19:24,071,869...24,202,394
G
Tlr9
toll-like receptor 9
ISO
protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:23026026
RGD:18337477
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
disease_progression
ISO
protein:increased expression:serum (human) protein:increased expression:blood serum(human) mRNA:increased expression:liver
RGD
PMID:9047083 PMID:21275501 PMID:17158635
RGD:14995307 , RGD:407420272 , RGD:38501106
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22961000
NCBI chr 9:21,015,364...21,042,689
Ensembl chr 9:21,015,364...21,042,539
G
Ubd
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Utp4
UTP4 small subunit processome component
ISO
North American Indian childhood cirrhosis, OMIM:604901, R565W
RGD
PMID:12417987
RGD:1600653
NCBI chr 8:107,620,272...107,649,726
Ensembl chr 8:107,620,268...107,649,720
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
susceptibility
ISO
DNA:polymorphism: : DNA:SNP: :
GAD RGD
PMID:15118671 PMID:15683428 PMID:19376604
RGD:1331525 , RGD:14402024 , RGD:14401750
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:liver protein:increased expression:plasma:
RGD
PMID:26627607 PMID:26615570
RGD:11528851 , RGD:11538286
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Zc3h12a
zinc finger CCCH type containing 12A
IAGP
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
G
Il12rb2
interleukin 12 receptor, beta 2
ISO
ClinVar Annotator: match by term: IL12RB2-related condition
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:67,263,914...67,353,277
Ensembl chr 6:67,268,302...67,353,172
G
Lbr
lamin B receptor
ISO
ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA | ClinVar Annotator: match by term: Reynolds syndrome
OMIM ClinVar
PMID:18382993 PMID:20522425 PMID:23824842 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:30448303 PMID:32827848 PMID:34567078 PMID:36307859 More...
NCBI chr 1:181,642,880...181,669,933
Ensembl chr 1:181,642,900...181,670,611
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all